| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Letter in reply. Journal of Comparative Effectiveness Research. PMID 34608814 DOI: 10.2217/cer-2021-0203 |
0.01 |
|
| 2021 |
Ried M, Kovács J, Markowiak T, Müller K, Huppertz G, Koller M, Winter H, Klotz LV, Hatz R, Zimmermann J, Passlick B, Schmid S, Hassan M, Eichhorn ME, Hofmann HS. Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies-A Retrospective, Multicentre Study. Cancers. 13. PMID 34572806 DOI: 10.3390/cancers13184580 |
0.01 |
|
| 2021 |
Keller CW, Lopez JA, Wendel EM, Ramanathan S, Gross CC, Klotz L, Reindl M, Dale RC, Wiendl H, Rostásy K, Brilot F, Lünemann JD. Complement activation is a prominent feature of MOGAD. Annals of Neurology. PMID 34569094 DOI: 10.1002/ana.26226 |
0.01 |
|
| 2021 |
Sayyid RK, Klotz L, Benton JZ, Ma M, Woodruff P, Satkunasivam R, Terris MK, Wallis CJD, Klaassen Z. Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 34464250 DOI: 10.5489/cuaj.7272 |
0.01 |
|
| 2021 |
Krafczyk N, Klotz LO. FOXO transcription factors in antioxidant defense. Iubmb Life. PMID 34423888 DOI: 10.1002/iub.2542 |
0.01 |
|
| 2021 |
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, ... ... Klotz L, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders. 14: 17562864211039648. PMID 34422112 DOI: 10.1177/17562864211039648 |
0.01 |
|
| 2021 |
Klotz L. Re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.031. European Urology. PMID 34399997 DOI: 10.1016/j.eururo.2021.07.003 |
0.01 |
|
| 2021 |
Klotz LV, Gruenewald C, Bulut EL, Eichhorn F, Thomas M, Shah R, Kriegsmann M, Schmidt W, Kofler O, Winter H, Eichhorn ME. Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center Experience. Respiration; International Review of Thoracic Diseases. 1-9. PMID 34384085 DOI: 10.1159/000517334 |
0.01 |
|
| 2021 |
Tremblay S, Summers-Trasiewicz L, Pouliot F, Crook JM, Ding K, Klotz L, Toren P. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 34383590 DOI: 10.1097/JU.0000000000001946.03 |
0.01 |
|
| 2021 |
Bachert W, Klotz L, Sticht H, Enz R. Homodimerization of a proximal region within the C-terminus of the orphan G-protein coupled receptor GPR179. Neurochemistry International. 149: 105150. PMID 34333057 DOI: 10.1016/j.neuint.2021.105150 |
0.01 |
|
| 2021 |
Fisch D, Bozorgmehr F, Kazdal D, Kuon J, Klotz LV, Shah R, Eichhorn F, Kriegsmann M, Schneider MA, Muley T, Stenzinger A, Bischoff H, Christopoulos P. Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma. Frontiers in Oncology. 11: 673901. PMID 34307143 DOI: 10.3389/fonc.2021.673901 |
0.01 |
|
| 2021 |
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, ... ... Klotz L, et al. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt. PMID 34297142 DOI: 10.1007/s00115-021-01157-2 |
0.01 |
|
| 2021 |
Rolfes L, Pawlitzki M, Pfeuffer S, Nelke C, Lux A, Pul R, Kleinschnitz C, Kleinschnitz K, Rogall R, Pape K, Bittner S, Zipp F, Warnke C, Goereci Y, Schroeter M, ... ... Klotz L, et al. Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34261812 DOI: 10.1212/NXI.0000000000001035 |
0.01 |
|
| 2021 |
Tremblay S, Summers-Trasiewicz L, Pouliot F, Crook JM, Ding K, Klotz L, Toren P. Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 34184929 DOI: 10.1097/JU.0000000000001946 |
0.01 |
|
| 2021 |
Klotz L. Adding prostate-specific membrane antigen positron emission tomography (PSMA PET) to our prostate cancer armamentarium raises many questions. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 15: 179-180. PMID 34127182 DOI: 10.5489/cuaj.7336 |
0.01 |
|
| 2021 |
Ayzenberg I, Richter D, Henke E, Asseyer S, Paul F, Trebst C, Hümmert MW, Havla J, Kümpfel T, Ringelstein M, Aktas O, Wildemann B, Jarius S, Häußler V, Stellmann JP, ... ... Klotz L, et al. Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34108267 DOI: 10.1212/NXI.0000000000000985 |
0.01 |
|
| 2021 |
Wallis CJD, Klotz L, Satkunasivam R, Klaassen Z. Not So "Active" Surveillance. International Journal of Radiation Oncology, Biology, Physics. 110: 716-717. PMID 34089678 DOI: 10.1016/j.ijrobp.2021.01.030 |
0.01 |
|
| 2021 |
Joeris T, Gomez-Casado C, Holmkvist P, Tavernier SJ, Silva-Sanchez A, Klotz L, Randall TD, Mowat AM, Kotarsky K, Malissen B, Agace WW. Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3CD8 T. Science Immunology. 6. PMID 34088744 DOI: 10.1126/sciimmunol.abd3774 |
0.01 |
|
| 2021 |
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane BR, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F. Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited. European Urology Oncology. PMID 34083164 DOI: 10.1016/j.euo.2021.05.004 |
0.01 |
|
| 2021 |
Pfeuffer S, Rolfes L, Hackert J, Kleinschnitz K, Ruck T, Wiendl H, Klotz L, Kleinschnitz C, Meuth SG, Pul R. Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211012227. PMID 33975489 DOI: 10.1177/13524585211012227 |
0.01 |
|
| 2021 |
Eichhorn F, Kriegsmann M, Klotz LV, Kriegsmann K, Muley T, Zgorzelski C, Christopoulos P, Winter H, Eichhorn ME. Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis. Cancers. 13. PMID 33922610 DOI: 10.3390/cancers13092046 |
0.01 |
|
| 2021 |
Philipp TM, Will A, Richter H, Winterhalter PR, Pohnert G, Steinbrenner H, Klotz LO. A coupled enzyme assay for detection of selenium-binding protein 1 (SELENBP1) methanethiol oxidase (MTO) activity in mature enterocytes. Redox Biology. 43: 101972. PMID 33901808 DOI: 10.1016/j.redox.2021.101972 |
0.01 |
|
| 2021 |
Fleck AK, Hucke S, Teipel F, Eschborn M, Janoschka C, Liebmann M, Wami H, Korn L, Pickert G, Hartwig M, Wirth T, Herold M, Koch K, Falk-Paulsen M, Dobrindt U, ... ... Klotz L, et al. Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity. Brain : a Journal of Neurology. PMID 33899089 DOI: 10.1093/brain/awab040 |
0.01 |
|
| 2021 |
Bozorgmehr F, Kazdal D, Chung I, Kirchner M, Magios N, Kriegsmann M, Allgäuer M, Klotz LV, Muley T, El Shafie RA, Fischer JR, Faehling M, Stenzinger A, Thomas M, Christopoulos P. Versus Secondary Metastatic -Mutated Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11: 640048. PMID 33898315 DOI: 10.3389/fonc.2021.640048 |
0.01 |
|
| 2021 |
Gross CC, Schulte-Mecklenbeck A, Madireddy L, Pawlitzki M, Strippel C, Räuber S, Krämer J, Rolfes L, Ruck T, Beuker C, Schmidt-Pogoda A, Lohmann L, Schneider-Hohendorf T, Hahn T, Schwab N, ... ... Klotz L, et al. Classification of neurological diseases using multi-dimensional cerebrospinal fluid analysis. Brain : a Journal of Neurology. PMID 33848319 DOI: 10.1093/brain/awab147 |
0.01 |
|
| 2021 |
Adams GS, Converse BA, Hales AH, Klotz LE. People systematically overlook subtractive changes. Nature. 592: 258-261. PMID 33828317 DOI: 10.1038/s41586-021-03380-y |
0.01 |
|
| 2021 |
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane B, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F. Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines. European Urology Oncology. PMID 33814342 DOI: 10.1016/j.euo.2021.03.005 |
0.01 |
|
| 2021 |
Ziemssen T, Albrecht H, Haas J, Klotz L, Lang M, Lassek C, Schmidt S, Ettle B, Schulze-Topphoff U. Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients. Frontiers in Neurology. 12: 637107. PMID 33763018 DOI: 10.3389/fneur.2021.637107 |
0.01 |
|
| 2021 |
Pfeuffer S, Ruck T, Pul R, Rolfes L, Korsukewitz C, Pawlitzki M, Wildemann B, Klotz L, Kleinschnitz C, Scalfari A, Wiendl H, Meuth SG. Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33712515 DOI: 10.1136/jnnp-2020-325304 |
0.01 |
|
| 2021 |
Klotz L, Pinthus J. The 'C' Words: parallels and analogies between Prostate Cancer and Covid-19. World Journal of Urology. PMID 33704506 DOI: 10.1007/s00345-021-03627-3 |
0.01 |
|
| 2021 |
Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, et al. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urologic Oncology. PMID 33676851 DOI: 10.1016/j.urolonc.2021.01.027 |
0.01 |
|
| 2021 |
Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Efficacy classification of modern therapies in multiple sclerosis. Journal of Comparative Effectiveness Research. PMID 33620251 DOI: 10.2217/cer-2020-0267 |
0.01 |
|
| 2021 |
Klotz L, Grudén S, Axén N, Gauffin C, Wassberg C, Bjartell A, Giddens J, Incze P, Jansz K, Jievaltas M, Rendon R, Richard PO, Ulys A, Tammela TL. Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients. European Urology Focus. PMID 33583762 DOI: 10.1016/j.euf.2021.02.003 |
0.01 |
|
| 2021 |
Sayyid RK, Klotz L, Benton JZ, Lodh A, Lambert JH, Woodruff P, Lokeshwar SD, Madi R, Goldberg H, Terris MK, Wallis CJD, Klaassen Z. Influence of Sociodemographic Factors on Definitive Intervention Among Low-Risk Active Surveillance Patients. Urology. PMID 33577898 DOI: 10.1016/j.urology.2021.01.053 |
0.01 |
|
| 2021 |
Lohmann L, Lammerskitten A, Korsen M, Dodel R, Gaul C, Hamer HM, Kleineberg NN, Ludolph AC, Mayer G, Poli S, Saur D, Steinhoff BJ, Timmermann L, Klotz L, Meuth SG. Status of Clinical Research in Neurology in Germany - A National Survey. European Journal of Neurology. PMID 33539600 DOI: 10.1111/ene.14763 |
0.01 |
|
| 2021 |
Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Machado A, Levental M, Ghai S, Chang S, Milot L, Patel C, Kassam Z, Moore C, Kasivisanathan V, et al. Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 33538782 DOI: 10.1001/jamaoncol.2020.7589 |
0.01 |
|
| 2021 |
Eichhorn F, Klotz LV, Kriegsmann M, Bischoff H, Schneider MA, Muley T, Kriegsmann K, Haberkorn U, Heussel CP, Savai R, Zoernig I, Jaeger D, Thomas M, Hoffmann H, Winter H, et al. Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung Cancer (Amsterdam, Netherlands). 153: 150-157. PMID 33529989 DOI: 10.1016/j.lungcan.2021.01.018 |
0.01 |
|
| 2021 |
Tauber S, Sieckmann MK, Erler K, Stahl W, Klotz LO, Steinbrenner H. Activation of Nrf2 by Electrophiles Is Largely Independent of the Selenium Status of HepG2 Cells. Antioxidants (Basel, Switzerland). 10. PMID 33498683 DOI: 10.3390/antiox10020167 |
0.01 |
|
| 2021 |
Beuker C, Strecker JK, Rawal R, Schmidt-Pogoda A, Ruck T, Wiendl H, Klotz L, Schäbitz WR, Sommer CJ, Minnerup H, Meuth SG, Minnerup J. Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-Analysis. Translational Stroke Research. PMID 33496918 DOI: 10.1007/s12975-021-00887-4 |
0.01 |
|
| 2021 |
Klotz L. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer. World Journal of Urology. PMID 33492425 DOI: 10.1007/s00345-020-03523-2 |
0.01 |
|
| 2021 |
Cirne F, Aghel N, Petropoulos JA, Klotz L, Lenihan DJ, Saad F, Pinthus J, Leong DP. THE CARDIOVASCULAR EFFECTS OF GNRH ANTAGONISTS IN MEN WITH PROSTATE CANCER. European Heart Journal. Cardiovascular Pharmacotherapy. PMID 33470403 DOI: 10.1093/ehjcvp/pvab005 |
0.01 |
|
| 2021 |
Asseyer S, Henke E, Trebst C, Hümmert MW, Wildemann B, Jarius S, Ringelstein M, Aktas O, Pawlitzki M, Korsen M, Klotz L, Siebert N, Ruprecht K, Bellmann-Strobl J, Wernecke KD, et al. Pain, depression and quality of life in adults with MOG-antibody associated disease. European Journal of Neurology. PMID 33423336 DOI: 10.1111/ene.14729 |
0.01 |
|
| 2021 |
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, ... ... Klotz L, et al. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33376202 DOI: 10.1073/pnas.2018457118 |
0.01 |
|
| 2021 |
Kayano PP, Klotz L. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Current Opinion in Urology. 31: 49-57. PMID 33196540 DOI: 10.1097/MOU.0000000000000838 |
0.01 |
|
| 2020 |
Hamilton RJ, Ding K, Crook JM, O'Callaghan CJ, Higano CS, Dearnaley DP, Horwitz EM, Goldenberg SL, Gospodarowicz MK, Klotz L. The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy. European Urology. PMID 33390282 DOI: 10.1016/j.eururo.2020.12.031 |
0.01 |
|
| 2020 |
Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, et al. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 33355501 DOI: 10.1097/JU.0000000000001362.03 |
0.01 |
|
| 2020 |
Pawlitzki M, Ahring S, Rolfes L, Dziewas R, Warnecke T, Suntrup-Krueger S, Wiendl H, Klotz L, Meuth SG, Labeit B. Dysphagia in NMOSD and MOGAD as a surrogate of brain involvement? European Journal of Neurology. PMID 33338309 DOI: 10.1111/ene.14691 |
0.01 |
|
| 2020 |
Fervaha G, Izard JP, Tripp DA, Aghel N, Shayegan B, Klotz L, Niazi T, Fradet V, Taussky D, Lavallée LT, Hamilton RJ, Brown I, Chin J, Gopaul D, Violette PD, et al. Psychological morbidity associated with prostate cancer: Rates and predictors of depression in the RADICAL PC study. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 33212008 DOI: 10.5489/cuaj.6912 |
0.01 |
|
| 2020 |
Shah R, Klotz LV, Chung I, Feißt M, Schneider MA, Riedel J, Bischoff H, Eichhorn ME, Thomas M. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol. Clinical Lung Cancer. PMID 33158765 DOI: 10.1016/j.cllc.2020.10.005 |
0.01 |
|
| 2020 |
Schneider-Hohendorf T, Schulte-Mecklenbeck A, Ostkamp P, Janoschka C, Pawlitzki M, Luessi F, Zipp F, Meuth SG, Klotz L, Wiendl H, Gross CC, Schwab N. High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520970103. PMID 33150829 DOI: 10.1177/1352458520970103 |
0.01 |
|
| 2020 |
Converse BA, Hancock PI, Klotz LE, Clarens AF, Adams GS. If humans design the planet: A call for psychological scientists to engage with climate engineering. The American Psychologist. PMID 33090814 DOI: 10.1037/amp0000656 |
0.01 |
|
| 2020 |
Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis. Journal of Comparative Effectiveness Research. PMID 33090003 DOI: 10.2217/cer-2020-0122 |
0.01 |
|
| 2020 |
Rosenzweig B, Bex A, Dotan ZA, Frydenberg M, Klotz L, Lotan Y, Schulman CC, Tsaur I, Ramon J. Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists. Urologic Oncology. PMID 33036903 DOI: 10.1016/j.urolonc.2020.09.015 |
0.01 |
|
| 2020 |
Saad F, Fleshner N, Pickles T, Niazi T, Lukka H, Pouliot F, Martins I, Klotz L. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 33026926 DOI: 10.1097/JU.0000000000001403 |
0.01 |
|
| 2020 |
Strauss M, Ehlers J, Gerß J, Klotz L, Reinecke H, Leischik R. [Status Quo - The requirements for medical habilitation in Germany]. Deutsche Medizinische Wochenschrift (1946). PMID 33022742 DOI: 10.1055/a-1210-5221 |
0.01 |
|
| 2020 |
Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, et al. MRI-guided transurethral ultrasound ablation of prostate cancer. The Journal of Urology. 101097JU000000000000. PMID 33021440 DOI: 10.1097/JU.0000000000001362 |
0.01 |
|
| 2020 |
Lim C, Abreu-Gomez J, Leblond MA, Carrion I, Vesprini D, Schieda N, Klotz L. When to biopsy Prostate Imaging and Data Reporting System version 2 (PI-RADSv2) assessment category 3 lesions? Use of clinical and imaging variables to predict cancer diagnosis at targeted biopsy. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 33007183 DOI: 10.5489/cuaj.6781 |
0.01 |
|
| 2020 |
Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, Buttmann M, Hümmert MW, Trebst C, Schroeder C, Ayzenberg I, Kleiter I, Hellwig K, Havla J, Kümpfel T, ... ... Klotz L, et al. Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Neurology. 95: 610. PMID 32989121 DOI: 10.1212/WNL.0000000000010633 |
0.01 |
|
| 2020 |
Baum P, Diers J, Haag J, Klotz L, Eichhorn F, Eichhorn M, Wiegering A, Winter H. Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany. Lung Cancer (Amsterdam, Netherlands). 149: 78-83. PMID 32980612 DOI: 10.1016/j.lungcan.2020.08.018 |
0.01 |
|
| 2020 |
Locke J, Herschorn S, Neu S, Klotz L, Kodama R, Carr L. Patients' perspective of telephone visits during the COVID-19 pandemic. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 14: E402-E406. PMID 32931728 DOI: 10.5489/cuaj.6758 |
0.01 |
|
| 2020 |
Locke J, Herschorn S, Neu S, Klotz L, Kodama R, Carr L. Patients' perspective of telephone visits during the COVID-19 pandemic. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 14: E402-E406. PMID 32931728 DOI: 10.5489/cuaj.6758 |
0.01 |
|
| 2020 |
Qu LG, Perera M, Lawrentschuk N, Umbas R, Klotz L. Scoping review: hotspots for COVID-19 urological research: what is being published and from where? World Journal of Urology. PMID 32909171 DOI: 10.1007/s00345-020-03434-2 |
0.01 |
|
| 2020 |
Starost L, Lindner M, Herold M, Xu YKT, Drexler HCA, Heß K, Ehrlich M, Ottoboni L, Ruffini F, Stehling M, Röpke A, Thomas C, Schöler HR, Antel J, Winkler J, ... ... Klotz L, et al. Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis. Acta Neuropathologica. PMID 32894330 DOI: 10.1007/S00401-020-02217-8 |
0.01 |
|
| 2020 |
Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hümmert MW, Ringelstein M, Rommer PS, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Höftberger R, Tobia R, Buttmann M, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Journal of Neuroinflammation. 17: 261. PMID 32883348 DOI: 10.1186/s12974-020-01824-2 |
0.01 |
|
| 2020 |
Gravas S, Ahmad M, Hernández-Porras A, Furriel F, Alvarez-Maestro M, Kumar A, Lee KS, Azodoh E, Mburugu P, Sanchez-Salas R, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, et al. Impact of COVID-19 on medical education: introducing homo digitalis. World Journal of Urology. PMID 32860535 DOI: 10.1007/s00345-020-03417-3 |
0.01 |
|
| 2020 |
Gerdes LA, Janoschka C, Eveslage M, Mannig B, Wirth T, Schulte-Mecklenbeck A, Lauks S, Glau L, Gross CC, Tolosa E, Flierl-Hecht A, Ertl-Wagner B, Barkhof F, Meuth SG, Kümpfel T, ... ... Klotz L, et al. Immune signatures of prodromal multiple sclerosis in monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 117: 21546-21556. PMID 32817525 DOI: 10.1073/Pnas.2003339117 |
0.01 |
|
| 2020 |
Sosnowski R, Kamecki H, Daneshmand S, Rudzinski JK, Bjurlin MA, Giganti F, Roobol MJ, Klotz L. Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol. Central European Journal of Urology. 73: 123-126. PMID 32782829 DOI: 10.5173/ceju.2020.0167 |
0.01 |
|
| 2020 |
Boehm K, Thomas A, Bex A, Black PC, Coburn M, Haferkamp A, Hamdy F, Kaufman RP, Klotz L, Lerner SP, Pushkar D, Ramon J, Rosenzweig B, Tsaur I. Outreach and influence of surgical societies` recommendations on minimally invasive surgery during the COVID-19 pandemic - an anonymized international urologic expert inquiry. Urology. PMID 32781078 DOI: 10.1016/j.urology.2020.07.043 |
0.01 |
|
| 2020 |
de la Rosette J, Laguna P, Álvarez-Maestro M, Eto M, Mochtar CA, Albayrak S, Mendoza-Valdes A, Ong TA, Khadgi S, Al-Terki A, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, et al. Cross-continental comparison of safety and protection measures amongst urologists during COVID-19. International Journal of Urology : Official Journal of the Japanese Urological Association. PMID 32772434 DOI: 10.1111/iju.14340 |
0.01 |
|
| 2020 |
Yamada Y, Ukimura O, Kaneko M, Matsugasumi T, Fujihara A, Vourganti S, Marks L, Sidana A, Klotz L, Salomon G, de la Rosette J. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World Journal of Urology. PMID 32728885 DOI: 10.1007/s00345-020-03366-x |
0.01 |
|
| 2020 |
Klotz L, Lughezzani G, Maffei D, Sánchez A, Pereira JG, Staerman F, Cash H, Luger F, Lopez L, Sanchez-Salas R, Abouassaly R, Shore ND, Eure G, Paciotti M, Astobieta A, et al. Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 32701437 DOI: 10.5489/cuaj.6712 |
0.01 |
|
| 2020 |
Perera M, Roberts MJ, Klotz L, Higano CS, Papa N, Sengupta S, Bolton D, Lawrentschuk N. Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer. Nature Reviews. Urology. PMID 32606361 DOI: 10.1038/s41585-020-0335-7 |
0.01 |
|
| 2020 |
Winnie Wang WL, Sorokin I, Aleksic I, Mian B, Fisher H, Kaufman R, Winer A, McNeill B, Gupta R, Tilki D, Fleshner N, Klotz L, DiRienzo AG, Tenniswood M. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 32579041 DOI: 10.1097/JU.0000000000001020.02 |
0.01 |
|
| 2020 |
Klotz LO, Simm A. [Aging and nutrition]. Zeitschrift Fur Gerontologie Und Geriatrie. 53: 283-284. PMID 32577888 DOI: 10.1007/s00391-020-01741-2 |
0.01 |
|
| 2020 |
Gravas S, Fournier G, Oya M, Summerton D, Scarpa RM, Chlosta P, Gkialas I, Xie LP, Rasyid N, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, de la Rosette J, et al. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines. European Urology Focus. PMID 32571743 DOI: 10.1016/j.euf.2020.06.006 |
0.01 |
|
| 2020 |
Klotz L. The history of intermittent androgen deprivation therapy - A Canadian story. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 14: 159-162. PMID 32525797 DOI: 10.5489/cuaj.6601 |
0.01 |
|
| 2020 |
Chittò M, Berger M, Berger P, Klotz L, Dröge P, Dobrindt U. IHF stabilizes pathogenicity island I of uropathogenic Escherichia coli strain 536 by attenuating integrase I promoter activity. Scientific Reports. 10: 9397. PMID 32523028 DOI: 10.1038/s41598-020-66215-2 |
0.01 |
|
| 2020 |
Gravas S, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, de la Rosette J. Impact of COVID-19 on Urology Practice: A Global Perspective and Snapshot Analysis. Journal of Clinical Medicine. 9. PMID 32503305 DOI: 10.3390/jcm9061730 |
0.01 |
|
| 2020 |
Ziemssen T, Hoffmann O, Klotz L, Schreiber H, Weber M, Rauser B. Study Protocol of AMASIA, a Non-Interventional Study to Gain First Insights on SPMS Patients Treated With Siponimod in Clinical Routine. Jmir Research Protocols. PMID 32499214 DOI: 10.2196/19598 |
0.01 |
|
| 2020 |
Steinbrenner H, Klotz LO. [Selenium and zinc: "antioxidants" for healthy aging?] Zeitschrift Fur Gerontologie Und Geriatrie. PMID 32468295 DOI: 10.1007/s00391-020-01735-0 |
0.01 |
|
| 2020 |
Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, et al. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study. Ebiomedicine. 56: 102807. PMID 32460167 DOI: 10.1016/J.Ebiom.2020.102807 |
0.01 |
|
| 2020 |
Bhindi B, Lokeshwar SD, Klaassen Z, Klotz L, Wallis CJD. Systematic review and meta-analysis of trials evaluating the role of adjuvant radiation after radical prostatectomy for prostate cancer: Implications for early salvage. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 32432529 DOI: 10.5489/cuaj.6440 |
0.01 |
|
| 2020 |
Bauman G, Ding K, Chin J, Nair S, Iaboni A, Crook J, Klotz L, Dearnaley D, Horwitz E, O'Callaghan C. Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis. Cureus. 12: e7983. PMID 32391232 DOI: 10.7759/cureus.7983 |
0.01 |
|
| 2020 |
Abrahamyan S, Eberspächer B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Grüter T, Tackenberg B, Paul F, Then-Bergh F, Kümpfel T, Weber F, et al. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32371533 DOI: 10.1136/Jnnp-2020-322941 |
0.01 |
|
| 2020 |
Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, Bayas A, Berthele A, Heesen C, Klotz L, Kümpfel T, Linker RA, Meuth SG, Paul F, Stangel M, et al. Is ε4 associated with cognitive performance in early MS? Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32358224 DOI: 10.1212/Nxi.0000000000000728 |
0.01 |
|
| 2020 |
Detsky JS, Ghiam AF, Mamedov A, Commisso K, Commisso A, Zhang L, Liu S, Klotz L, Loblaw A, Vesprini D. Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 32330406 DOI: 10.1097/Ju.0000000000001091 |
0.01 |
|
| 2020 |
Preisser F, Cooperberg MR, Crook J, Feng F, Graefen M, Karakiewicz PI, Klotz L, Montironi R, Nguyen PL, D'Amico AV. Intermediate-risk Prostate Cancer: Stratification and Management. European Urology Oncology. PMID 32303478 DOI: 10.1016/j.euo.2020.03.002 |
0.01 |
|
| 2020 |
Hird AE, Magee DE, Bhindi B, Ye XY, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z, Wallis CJD. A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. PMID 32278840 DOI: 10.1016/j.clgc.2020.02.005 |
0.01 |
|
| 2020 |
Schulte R, Wohlleber D, Unrau L, Geers B, Metzger C, Erhardt A, Tiegs G, van Rooijen N, Heukamp LC, Klotz L, Knolle PA, Diehl L. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis. International Journal of Molecular Sciences. 21. PMID 32260486 DOI: 10.3390/ijms21072523 |
0.01 |
|
| 2020 |
Pickert G, Wirtz S, Matzner J, Ashfaq-Khan M, Heck R, Rosigkeit S, Thies D, Surabattula R, Ehmann D, Wehkamp J, Aslam M, He G, Weigert A, Foerster F, Klotz L, et al. Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis. Gastroenterology. PMID 32251667 DOI: 10.1053/j.gastro.2020.03.064 |
0.01 |
|
| 2020 |
Herrera-Caceres JO, Wettstein MS, Goldberg H, Toi A, Chandrasekar T, Woon DTS, Ahmad AE, Sanmamed-Salgado N, Alhunaidi O, Ajib K, Nason G, Tan GH, Fleshner N, Klotz L. Utility of digital rectal examination in a population with prostate cancer treated with active surveillance. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 32223879 DOI: 10.5489/cuaj.6341 |
0.01 |
|
| 2020 |
Sohrabi Y, Sonntag GVH, Braun LC, Lagache SMM, Liebmann M, Klotz L, Godfrey R, Kahles F, Waltenberger J, Findeisen HM. LXR Activation Induces a Proinflammatory Trained Innate Immunity-Phenotype in Human Monocytes. Frontiers in Immunology. 11: 353. PMID 32210962 DOI: 10.3389/fimmu.2020.00353 |
0.01 |
|
| 2020 |
Heitmann H, Haller B, Tiemann L, Mühlau M, Berthele A, Tölle TR, Salmen A, Ambrosius B, Bayas A, Asseyer S, Hartung HP, Heesen C, Stangel M, Wildemann B, Haars S, ... ... Klotz L, et al. Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. Pain. 161: 787-796. PMID 32197038 DOI: 10.1097/J.Pain.0000000000001767 |
0.01 |
|
| 2020 |
Wang WW, Sorokin I, Aleksic I, Mian B, Fisher H, Kaufman R, Winer A, McNeill B, Gupta R, Tilki D, Fleshner N, Klotz L, DiRienzo AG, Tenniswood M. Expression of Small Non-coding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease. The Journal of Urology. 101097JU000000000000. PMID 32191585 DOI: 10.1097/Ju.0000000000001020 |
0.01 |
|
| 2020 |
Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 32175794 DOI: 10.1097/JU.0000000000000595.02 |
0.01 |
|
| 2020 |
Meyer Zu Hörste G, Gross CC, Klotz L, Schwab N, Wiendl H. Next-Generation Neuroimmunology: New Technologies to Understand Central Nervous System Autoimmunity. Trends in Immunology. PMID 32147112 DOI: 10.1016/j.it.2020.02.005 |
0.01 |
|
| 2020 |
Saad F, Fleshner N, Pickles T, Niazi T, Lukka H, Pouliot F, Martins I, Klotz L. Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 32096678 DOI: 10.1097/Ju.0000000000000809 |
0.01 |
|
| 2020 |
Heming M, Lohmann L, Schulte-Mecklenbeck A, Brix T, Gross CC, Wiendl H, Klotz L, Meyer Zu Hörste G. Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis. Journal of Neuroimmunology. 341: 577171. PMID 32007787 DOI: 10.1016/j.jneuroim.2020.577171 |
0.01 |
|
| 2020 |
Leong DP, Fradet V, Shayegan B, Duceppe E, Siemens R, Niazi T, Klotz L, Brown I, Chin J, Lavallee L, Mousavi N, Luke P, Lukka H, Gopaul D, Violette P, et al. Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study. The Journal of Urology. 101097JU000000000000. PMID 31899651 DOI: 10.1097/Ju.0000000000000714 |
0.01 |
|
| 2020 |
Möhn N, Pfeuffer S, Ruck T, Gross CC, Skripuletz T, Klotz L, Wiendl H, Stangel M, Meuth SG. Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 31826986 DOI: 10.1212/NXI.0000000000000654 |
0.01 |
|
| 2019 |
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Cornelissen C, Ettle B. Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab. Multiple Sclerosis and Related Disorders. 39: 101893. PMID 31865273 DOI: 10.1016/j.msard.2019.101893 |
0.01 |
|
| 2019 |
Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Tröscher AR, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, Plate H, Kuhlmann T, Schwaninger M, Brück W, Pawlitzki M, ... ... Klotz L, et al. CD8 T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nature Communications. 10: 5779. PMID 31852955 DOI: 10.1038/s41467-019-13593-5 |
0.01 |
|
| 2019 |
Pouliot F, Rouleau M, Neveu B, Toren P, Morin F, Vélot L, Ding K, Caron P, Lacombe L, Lévesque É, Klotz L, Guillemette C. Extragonadal Steroids Contribute Significantly to the Androgen Receptor Activity and Castration Resistance Development in Recurrent Prostate Cancers after Primary Therapy. The Journal of Urology. 101097JU000000000000. PMID 31845837 DOI: 10.1097/Ju.0000000000000699 |
0.01 |
|
| 2019 |
Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, Buttmann M, Hümmert MW, Trebst C, Schroeder C, Ayzenberg I, Kleiter I, Hellwig K, Havla J, Kümpfel T, ... ... Klotz L, et al. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Neurology. PMID 31796527 DOI: 10.1212/Wnl.0000000000008684 |
0.01 |
|
| 2019 |
Liu H, Ding J, Köhnlein K, Urban N, Ori A, Villavicencio-Lorini P, Walentek P, Klotz LO, Hollemann T, Pfirrmann T. The GID ubiquitin ligase complex is a regulator of AMPK activity and organismal lifespan. Autophagy. 1-17. PMID 31795790 DOI: 10.1080/15548627.2019.1695399 |
0.01 |
|
| 2019 |
Klotz L, Pond G, Loblaw A, Sugar L, Moussa M, Berman D, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M, Fleshner N, Ghai S, Chin J, Haider M. Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up. European Urology. PMID 31708295 DOI: 10.1016/j.eururo.2019.10.007 |
0.01 |
|
| 2019 |
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD. Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 31682087 DOI: 10.1002/acn3.50935 |
0.01 |
|
| 2019 |
Eichhorn F, Klotz LV, Muley T, Kobinger S, Winter H, Eichhorn ME. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis. Lung Cancer (Amsterdam, Netherlands). 138: 95-101. PMID 31678832 DOI: 10.1016/j.lungcan.2019.10.018 |
0.01 |
|
| 2019 |
Klotz L. Active surveillance in intermediate risk prostate cancer. Bju International. PMID 31647166 DOI: 10.1111/bju.14935 |
0.01 |
|
| 2019 |
Chittò M, Berger M, Klotz L, Dobrindt U. Sub-Inhibitory concentrations of SOS-Response inducing antibiotics stimulate integrase expression and excision of pathogenicity islands in uropathogenic Escherichia coli strain 536. International Journal of Medical Microbiology : Ijmm. 151361. PMID 31640923 DOI: 10.1016/j.ijmm.2019.151361 |
0.01 |
|
| 2019 |
Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. Cancer. PMID 31639200 DOI: 10.1002/Cncr.32557 |
0.01 |
|
| 2019 |
von Martial S, Brix TJ, Klotz L, Neuhaus P, Berger K, Warnke C, Meuth SG, Wiendl H, Dugas M. EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseases. Plos One. 14: e0223886. PMID 31613917 DOI: 10.1371/journal.pone.0223886 |
0.01 |
|
| 2019 |
Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Comparison of MRI- and TRUS-Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy-Naive Men: A Systematic Review and Meta-Analysis. The Journal of Urology. 101097JU000000000000. PMID 31609177 DOI: 10.1097/JU.0000000000000595 |
0.01 |
|
| 2019 |
Klotz L, Wendler O, Frischknecht R, Shigemoto R, Schulze H, Enz R. Localization of group II and III metabotropic glutamate receptors at pre- and postsynaptic sites of inner hair cell ribbon synapses. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201901543R. PMID 31585509 DOI: 10.1096/fj.201901543R |
0.01 |
|
| 2019 |
Barclay N, Klotz L. Role of community participation for green stormwater infrastructure development. Journal of Environmental Management. 251: 109620. PMID 31569019 DOI: 10.1016/J.Jenvman.2019.109620 |
0.01 |
|
| 2019 |
Herich S, Schneider-Hohendorf T, Rohlmann A, Khaleghi Ghadiri M, Schulte-Mecklenbeck A, Zondler L, Janoschka C, Ostkamp P, Richter J, Breuer J, Dimitrov S, Rammensee HG, Grauer OM, Klotz L, Gross CC, et al. Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis. Brain : a Journal of Neurology. PMID 31563951 DOI: 10.1093/brain/awz301 |
0.01 |
|
| 2019 |
Köhnlein K, Urban N, Guerrero-Gómez D, Steinbrenner H, Urbánek P, Priebs J, Koch P, Kaether C, Miranda-Vizuete A, Klotz LO. A Caenorhabditis elegans ortholog of human selenium-binding protein 1 is a pro-aging factor protecting against selenite toxicity. Redox Biology. 28: 101323. PMID 31557719 DOI: 10.1016/j.redox.2019.101323 |
0.01 |
|
| 2019 |
Papaevgeniou N, Hoehn A, Tur JA, Klotz LO, Grune T, Chondrogianni N. Sugar-derived AGEs accelerate pharyngeal pumping rate and increase the lifespan of . Free Radical Research. 1-12. PMID 31514551 DOI: 10.1080/10715762.2019.1661403 |
0.01 |
|
| 2019 |
Schwab N, Schneider-Hohendorf T, Pignolet B, Bucciarelli F, Scandella L, Ciron J, Biotti D, Lebrun-Frenay C, Mathey G, Clavelou P, Pelletier J, Ostkamp P, Meinl I, Windhagen S, Klotz L, et al. Prospective validation of the PML risk biomarker l-Selectin and influence of natalizumab extended intervals. Neurology. PMID 31439633 DOI: 10.1212/WNL.0000000000008135 |
0.01 |
|
| 2019 |
Ruck T, Schulte-Mecklenbeck A, Pfeuffer S, Heming M, Klotz L, Windhagen S, Kleinschnitz C, Gross CC, Wiendl H, Meuth SG. Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study. Ebiomedicine. PMID 31371192 DOI: 10.1016/j.ebiom.2019.07.062 |
0.01 |
|
| 2019 |
Oake JD, Patel P, Lavallée LT, Lattouf JB, Saarela O, Klotz L, Moore RB, Kapoor A, Finelli A, Rendon RA, Kawakami J, So A, Drachenberg DE. Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large Canadian multi-institutional database. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 31348746 DOI: 10.5489/cuaj.5941 |
0.01 |
|
| 2019 |
Ambrée O, Ruland C, Zwanzger P, Klotz L, Baune BT, Arolt V, Scheu S, Alferink J. Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice. International Journal of Molecular Sciences. 20. PMID 31319604 DOI: 10.3390/Ijms20143512 |
0.01 |
|
| 2019 |
Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, et al. [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Der Nervenarzt. PMID 31297574 DOI: 10.1007/S00115-019-0760-0 |
0.01 |
|
| 2019 |
Klotz LV, Lindner M, Eichhorn ME, Grützner U, Koch I, Winter H, Kauke T, Duell T, Hatz RA. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma. Journal of Thoracic Disease. 11: 1963-1972. PMID 31285889 DOI: 10.21037/jtd.2019.04.93 |
0.01 |
|
| 2019 |
Klotz L. Apalutamide for Metastatic, Hormone-Responsive Prostate Cancer. The New England Journal of Medicine. 381: 84-86. PMID 31269371 DOI: 10.1056/NEJMe1905891 |
0.01 |
|
| 2019 |
van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, et al. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. European Urology Oncology. 2: 333-336. PMID 31200849 DOI: 10.1016/J.Euo.2018.08.017 |
0.01 |
|
| 2019 |
Klotz LV, Eberhardt R, Herth FJF, Winter H. [Interventional treatment of tracheopleural and bronchopleural fistulas]. Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen. PMID 31161248 DOI: 10.1007/s00104-019-0977-2 |
0.01 |
|
| 2019 |
Spella M, Lilis I, Pepe MA, Chen Y, Armaka M, Lamort AS, Zazara DE, Roumelioti F, Vreka M, Kanellakis NI, Wagner DE, Giannou AD, Armenis V, Arendt KA, Klotz LV, et al. Club cells form lung adenocarcinomas and maintain the alveoli of adult mice. Elife. 8. PMID 31140976 DOI: 10.7554/Elife.45571 |
0.01 |
|
| 2019 |
Klotz L. Contemporary approach to active surveillance for favorable risk prostate cancer. Asian Journal of Urology. 6: 146-152. PMID 31061800 DOI: 10.1016/j.ajur.2018.12.003 |
0.01 |
|
| 2019 |
Eichhorn F, Klotz LV, Bischoff H, Thomas M, Lasitschka F, Winter H, Hoffmann H, Eichhorn ME. Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial. Bmc Cancer. 19: 413. PMID 31046714 DOI: 10.1186/s12885-019-5624-2 |
0.01 |
|
| 2019 |
Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, Nebel G, Glander S, et al. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Science Translational Medicine. 11. PMID 31043571 DOI: 10.1126/scitranslmed.aao5563 |
0.01 |
|
| 2019 |
Heming M, Schulte-Mecklenbeck A, Brix T, Wolbert J, Ruland T, Klotz L, Meuth SG, Gross CC, Wiendl H, Meyer Zu Hörste G. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies. Frontiers in Immunology. 10: 515. PMID 30984164 DOI: 10.3389/fimmu.2019.00515 |
0.01 |
|
| 2019 |
Klotz L, Havla J, Schwab N, Hohlfeld R, Barnett M, Reddel S, Wiendl H. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment. Therapeutic Advances in Neurological Disorders. 12: 1756286419836571. PMID 30967901 DOI: 10.1177/1756286419836571 |
0.01 |
|
| 2019 |
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C. Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e548. PMID 30882022 DOI: 10.1212/NXI.0000000000000548 |
0.01 |
|
| 2019 |
Chandrasekar T, Herrera-Caceres JO, Klotz L. Active surveillance in intermediate risk prostate cancer. Archivos Espanoles De Urologia. 72: 157-166. PMID 30855017 |
0.01 |
|
| 2019 |
Wallis CJD, Klotz L, Klaassen Z. Re: Prostate Cancer-specific Mortality Across Gleason Scores in Black vs Nonblack Men. European Urology. PMID 30819526 DOI: 10.1016/j.eururo.2019.02.019 |
0.01 |
|
| 2019 |
Klotz LV, Courty Y, Lindner M, Petit-Courty A, Stowasser A, Koch I, Eichhorn ME, Lilis I, Morresi-Hauf A, Arendt KAM, Pepe M, Giopanou I, Ntaliarda G, Behrend SJ, Oplopoiou M, et al. Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors. Cancer Medicine. PMID 30806043 DOI: 10.1002/cam4.2031 |
0.01 |
|
| 2019 |
Cherkas A, Mondol AS, Rüger J, Urban N, Popp J, Klotz LO, Schie IW. Label-free molecular mapping and assessment of glycogen in C. elegans. The Analyst. PMID 30793720 DOI: 10.1039/C8An02351D |
0.01 |
|
| 2019 |
Breuer J, Schneider-Hohendorf T, Ostkamp P, Herich S, Rakhade S, Antonijevic I, Klotz L, Wiendl H, Schwab N. VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells. International Immunology. PMID 30783682 DOI: 10.1093/intimm/dxz018 |
0.01 |
|
| 2019 |
Zhao F, Vesprini D, Liu RSC, Olkhov-Mitsel E, Klotz LH, Loblaw A, Liu SK, Bapat B. Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance. Urologic Oncology. PMID 30777394 DOI: 10.1016/J.Urolonc.2019.01.031 |
0.01 |
|
| 2019 |
Zhang M, Milot L, Khalvati F, Sugar L, Downes M, Baig SM, Klotz L, Haider MA. Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy. Radiology. 180712. PMID 30694165 DOI: 10.1148/radiol.2019180712 |
0.01 |
|
| 2019 |
Rouleau M, Lemire F, Déry M, Thériault B, Dubois G, Fradet Y, Toren P, Guillemette C, Lacombe L, Klotz L, Saad F, Guérette D, Pouliot F. Discordance between testosterone measurement methods in castrated prostate cancer patients. Endocrine Connections. PMID 30673630 DOI: 10.1530/Ec-18-0476 |
0.01 |
|
| 2019 |
van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, ... Klotz L, et al. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World Journal of Urology. PMID 30671638 DOI: 10.1007/s00345-019-02636-7 |
0.01 |
|
| 2019 |
Salari K, Kuppermann D, Preston MA, Dahl DM, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS. Active Surveillance of Prostate Cancer is a Viable Option in Men Younger Than 60 Years. The Journal of Urology. PMID 30664083 DOI: 10.1097/JU.0000000000000031 |
0.01 |
|
| 2019 |
Schulte-Mecklenbeck A, Kleffner I, Beuker C, Wirth T, Hartwig M, Schmidt-Pogoda A, Klotz L, Hansen W, Wiendl H, Meuth SG, Gross CC, Minnerup J. Immunophenotyping of cerebrospinal fluid cells in ischemic stroke. European Journal of Neurology. PMID 30659722 DOI: 10.1111/ene.13909 |
0.01 |
|
| 2019 |
Glicksman R, Sanmamed N, Thoms J, Zlotta AR, Finelli A, van der Kwast T, Sweet J, Jewett M, Klotz LH, Rosewall T, Fleshner NE, Bristow RG, Warde P, Berlin A. A phase I pilot study of pre-operative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes. International Journal of Radiation Oncology, Biology, Physics. PMID 30625410 DOI: 10.1016/J.Ijrobp.2018.12.054 |
0.01 |
|
| 2019 |
Scheu S, Ali S, Mann-Nüttel R, Richter L, Arolt V, Dannlowski U, Kuhlmann T, Klotz L, Alferink J. Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity. International Journal of Molecular Sciences. 20. PMID 30621022 DOI: 10.3390/Ijms20010190 |
0.01 |
|
| 2019 |
Bass R, Roberto D, Wang DZ, Cantu FP, Mohamadi RM, Kelley SO, Klotz L, Venkateswaran V. Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model. Anticancer Research. 39: 113-118. PMID 30591447 DOI: 10.21873/Anticanres.13086 |
0.01 |
|
| 2019 |
Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer. The Journal of Urology. 201: 113-119. PMID 30577402 DOI: 10.1016/j.juro.2018.07.040 |
0.01 |
|
| 2018 |
Wallis CJD, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z. Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and Enzalutamide. European Urology Oncology. 1: 238-241. PMID 31102627 DOI: 10.1016/j.euo.2018.04.004 |
0.01 |
|
| 2018 |
Lange JM, Gulati R, Leonardson AS, Lin DW, Newcomb LF, Trock BJ, Carter HB, Cooperberg MR, Cowan JE, Klotz LH, Etzioni R. ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS. The Annals of Applied Statistics. 12: 1773-1795. PMID 30627300 DOI: 10.1214/17-Aoas1130 |
0.01 |
|
| 2018 |
Schmidt-Pogoda A, Strecker JK, Liebmann M, Massoth C, Beuker C, Hansen U, König S, Albrecht S, Bock S, Breuer J, Sommer C, Schwab N, Wiendl H, Klotz L, Minnerup J. Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation. Plos One. 13: e0209871. PMID 30589884 DOI: 10.1371/journal.pone.0209871 |
0.01 |
|
| 2018 |
Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, et al. Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). Journal of Neurology. PMID 30515631 DOI: 10.1007/S00415-018-9142-Y |
0.01 |
|
| 2018 |
Steinbrenner H, Micoogullari M, Hoang NA, Bergheim I, Klotz LO, Sies H. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biology. 20: 489-495. PMID 30469030 DOI: 10.1016/j.redox.2018.11.004 |
0.01 |
|
| 2018 |
Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, Linker RA, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, ... ... Klotz L, et al. Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation. Journal of Neurology. PMID 30446966 DOI: 10.1007/s00415-018-9117-z |
0.01 |
|
| 2018 |
Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Sondermann W, Pul R, Kleinschnitz C, Wiendl H, Meuth SG, Klotz L. Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells. Neurology. PMID 30404783 DOI: 10.1212/WNL.0000000000006648 |
0.01 |
|
| 2018 |
Hoang NA, Richter F, Schubert M, Lorkowski S, Klotz LO, Steinbrenner H. Differential capability of metabolic substrates to promote hepatocellular lipid accumulation. European Journal of Nutrition. PMID 30368556 DOI: 10.1007/s00394-018-1847-2 |
0.01 |
|
| 2018 |
Schultz NM, Shore ND, Chowdhury S, Klotz LH, Concepcion RS, Penson DF, Karsh LI, Yang H, Brown BA, Barlev A, Flanders SC. Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials. Bmc Urology. 18: 84. PMID 30285696 DOI: 10.1186/s12894-018-0397-5 |
0.01 |
|
| 2018 |
Gille A, Turkistani A, Tsitsipatis D, Hou X, Tauber S, Hamann I, Urban N, Erler K, Steinbrenner H, Klotz LO. Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate. Redox Biology. 20: 19-27. PMID 30261343 DOI: 10.1016/j.redox.2018.09.010 |
0.01 |
|
| 2018 |
Roberto D, Klotz LH, Venkateswaran V. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner. The Prostate. PMID 30242861 DOI: 10.1002/pros.23720 |
0.01 |
|
| 2018 |
Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf JB, van der Kwast T, et al. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation. Bmc Urology. 18: 78. PMID 30200929 DOI: 10.1186/S12894-018-0392-X |
0.01 |
|
| 2018 |
Schultz NM, Shore ND, Chowdhury S, Klotz LH, Concepcion RS, Penson DF, Karsh LI, Yang H, Brown BA, Barlev A, Flanders SC. Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials. Bmc Urology. 18: 77. PMID 30189902 DOI: 10.1186/s12894-018-0387-7 |
0.01 |
|
| 2018 |
Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. Prostate Cancer and Prostatic Diseases. PMID 30131604 DOI: 10.1038/s41391-018-0079-0 |
0.01 |
|
| 2018 |
Seitz CB, Droby A, Zaubitzer L, Krämer J, Paradis M, Klotz L, Wiendl H, Groppa S, Meuth SG, Zipp F, Fleischer V. Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging. Journal of Neurology. PMID 30073502 DOI: 10.1007/s00415-018-8988-3 |
0.01 |
|
| 2018 |
Liebmann M, Hucke S, Koch K, Eschborn M, Ghelman J, Chasan AI, Glander S, Schädlich M, Kuhlencord M, Daber NM, Eveslage M, Beyer M, Dietrich M, Albrecht P, Stoll M, ... ... Klotz L, et al. Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. PMID 30072431 DOI: 10.1073/pnas.1721049115 |
0.01 |
|
| 2018 |
Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L. Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study. Frontiers in Immunology. 9: 1560. PMID 30050529 DOI: 10.3389/fimmu.2018.01560 |
0.01 |
|
| 2018 |
Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L. Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study. Frontiers in Immunology. 9: 1560. PMID 30050529 DOI: 10.3389/fimmu.2018.01560 |
0.01 |
|
| 2018 |
Oczkowski SJW, Klotz L, Mazzetti I, Alshamsi F, Chen ML, Foster G, Meade MO, Hamielec C. Furosemide and Albumin for Diuresis of Edema (FADE): A parallel-group, blinded, pilot randomized controlled trial. Journal of Critical Care. PMID 30037660 DOI: 10.1016/j.jcrc.2018.07.020 |
0.01 |
|
| 2018 |
Oczkowski SJW, Klotz L, Mazzetti I, Alshamsi F, Chen ML, Foster G, Meade MO, Hamielec C. Furosemide and Albumin for Diuresis of Edema (FADE): A parallel-group, blinded, pilot randomized controlled trial. Journal of Critical Care. PMID 30037660 DOI: 10.1016/j.jcrc.2018.07.020 |
0.01 |
|
| 2018 |
Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L. Oncologic and functional outcome of partial gland ablation with HIFU for localized prostate cancer. The Journal of Urology. PMID 30036514 DOI: 10.1016/j.juro.2018.07.040 |
0.01 |
|
| 2018 |
Toren P, Hoffman A, Ding K, Joncas FH, Turcotte V, Caron P, Pouliot F, Fradet Y, Levesque E, Guillemette C, Klotz LH. Serum sex steroids as prognostic biomarkers in patients receiving androgen deprivation therapy for recurrent prostate cancer: a post-hoc analysis of the PR.7 trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30021911 DOI: 10.1158/1078-0432.Ccr-18-1187 |
0.01 |
|
| 2018 |
Klotz L, Loblaw A, Sugar L, Moussa M, Berman DM, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M, Fleshner N, Ghai S, Chin J, Pond GR, Haider M. Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial. European Urology. PMID 30017404 DOI: 10.1016/j.eururo.2018.06.025 |
0.01 |
|
| 2018 |
Kegel F, Sne N, Rice T, Joy E, Shahsavar S, Collins CA, Gagarine M, Allard-Coutu A, Klotz L, Coates A, Kahnamoui K, Simunovic M. Independent Heath Facility Meets Cancer Care Ontario and Canadian Association of Gastroenterology Guidelines for Endoscopic Procedure Wait Times While Meeting Quality Indicators: A Retrospective Review. Canadian Journal of Gastroenterology & Hepatology. 2018: 4708270. PMID 29974039 DOI: 10.1155/2018/4708270 |
0.01 |
|
| 2018 |
Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ. Surveillance after prostate focal therapy. World Journal of Urology. PMID 29948045 DOI: 10.1007/s00345-018-2363-y |
0.01 |
|
| 2018 |
Schmitzer M, Winter H, Kneidinger N, Meimarakis G, Dick A, Schramm R, Klotz LV, Preissler G, Strobl N, von Dossow V, Schneider C, Weig T, Hatz R, Kauke T. Persistence of de novo donor specific HLA-Antibodies after lung transplantation: a potential marker of decreased patient survival. Hla. PMID 29888557 DOI: 10.1111/tan.13306 |
0.01 |
|
| 2018 |
Heming M, Gran S, Jauch SL, Fischer-Riepe L, Russo A, Klotz L, Hermann S, Schäfers M, Roth J, Barczyk-Kahlert K. Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids. Frontiers in Immunology. 9: 893. PMID 29867927 DOI: 10.3389/fimmu.2018.00893 |
0.01 |
|
| 2018 |
Klotz L. Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer. Jama Oncology. PMID 29852034 DOI: 10.1001/jamaoncol.2018.0748 |
0.01 |
|
| 2018 |
Bär L, Feger M, Fajol A, Klotz LO, Zeng S, Lang F, Hocher B, Föller M. Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proceedings of the National Academy of Sciences of the United States of America. PMID 29760049 DOI: 10.1073/Pnas.1800160115 |
0.01 |
|
| 2018 |
Klotz L. The future of active surveillance. Translational Andrology and Urology. 7: 256-259. PMID 29732284 DOI: 10.21037/tau.2018.01.12 |
0.01 |
|
| 2018 |
Klotz L, Shayegan B, Guillemette C, Collins LL, Gotto G, Guérette D, Jammal MP, Pickles T, Richard PO, Saad F. Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 12: 30-37. PMID 29680011 DOI: 10.5489/Cuaj.5116 |
0.01 |
|
| 2018 |
Klotz L. Prostate cancer prevention: proof is elusive. Bju International. 121: 487-488. PMID 29603894 DOI: 10.1111/bju.14184 |
0.01 |
|
| 2018 |
Lindner M, Klotz L, Wiendl H. Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity. Journal of Neurochemistry. PMID 29574788 DOI: 10.1111/jnc.14339 |
0.01 |
|
| 2018 |
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, ... ... Klotz L, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. The New England Journal of Medicine. PMID 29552975 DOI: 10.1056/Nejmoa1801993 |
0.01 |
|
| 2018 |
Klotz L, Loblaw A, Siemens R, Ouellette P, Kapoor A, Kebabdjian M, Zhang L, Saad F. A phase II, randomized, multicentre study comparing 10 months versus 4 months of degarelix (Firmagon®) therapy in prolonging the off treatment interval in men with localized prostate cancer receiving intermittent androgen deprivation therapy for biochemical recurrence following radical local therapy. The Journal of Urology. PMID 29534997 DOI: 10.1016/J.Juro.2018.03.010 |
0.01 |
|
| 2018 |
von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, et al. Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e446. PMID 29511705 DOI: 10.1212/Nxi.0000000000000446 |
0.01 |
|
| 2018 |
Tsitsipatis D, Gopal K, Steinbrenner H, Klotz LO. FOXO1 cysteine-612 mediates stimulatory effects of the coregulators CBP and PGC1α on FOXO1 basal transcriptional activity. Free Radical Biology & Medicine. PMID 29496617 DOI: 10.1016/j.freeradbiomed.2018.02.034 |
0.01 |
|
| 2018 |
Schneider-Hohendorf T, Görlich D, Savola P, Kelkka T, Mustjoki S, Gross CC, Owens GC, Klotz L, Dornmair K, Wiendl H, Schwab N. Sex bias in MHC I-associated shaping of the adaptive immune system. Proceedings of the National Academy of Sciences of the United States of America. PMID 29440397 DOI: 10.1073/pnas.1716146115 |
0.01 |
|
| 2018 |
Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options. The Journal of Urology. PMID 29331546 DOI: 10.1016/j.juro.2018.01.002 |
0.01 |
|
| 2017 |
Wallis C, Cheung D, Klotz L, Chalasani V, Leao R, Garisto J, Morton G, Nam R, Tannock I, Satkunasivam R. Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 29381460 DOI: 10.5489/cuaj.4736 |
0.01 |
|
| 2017 |
Graf J, Leussink VI, Dehmel T, Ringelstein M, Goebels N, Adams O, MacKenzie CR, Warnke C, Feldt T, Lammerskitten A, Klotz L, Meuth S, Wiendl H, Hartung HP, Aktas O, et al. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy. Annals of Clinical and Translational Neurology. 4: 909-914. PMID 29296620 DOI: 10.1002/Acn3.491 |
0.01 |
|
| 2017 |
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Medin J, Cornelissen C. Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 29274026 DOI: 10.1007/s13311-017-0595-y |
0.01 |
|
| 2017 |
Creed J, Klotz L, Harbottle A, Maggrah A, Reguly B, George A, Gnanapragasm V. A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'. World Journal of Urology. PMID 29248950 DOI: 10.1007/s00345-017-2152-z |
0.01 |
|
| 2017 |
Liu RSC, Olkhov-Mitsel E, Jeyapala R, Zhao F, Commisso K, Klotz L, Loblaw A, Liu SK, Vesprini D, Fleshner NE, Bapat B. Assessment of serum microRNA biomarkers for predicting reclassification of prostate cancer patients on active surveillance. The Journal of Urology. PMID 29246734 DOI: 10.1016/J.Juro.2017.12.006 |
0.01 |
|
| 2017 |
Guy DE, Vandersluis A, Klotz LH, Fleshner N, Kiss A, Parker C, Venkateswaran V. Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance. Prostate Cancer and Prostatic Diseases. PMID 29242596 DOI: 10.1038/s41391-017-0010-0 |
0.01 |
|
| 2017 |
Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options. The Journal of Urology. PMID 29203269 DOI: 10.1016/j.juro.2017.11.095 |
0.01 |
|
| 2017 |
Mayer MJ, Klotz LH, Venkateswaran V. Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells. Anticancer Research. 37: 6601-6607. PMID 29187435 DOI: 10.21873/anticanres.12117 |
0.01 |
|
| 2017 |
Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R. Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts. Annals of Internal Medicine. PMID 29181514 DOI: 10.7326/M17-0548 |
0.01 |
|
| 2017 |
Tomasi R, Betz D, Schlager S, Kammerer T, Hoechter DJ, Weig T, Slinger P, Klotz LV, Zwißler B, Marczin N, von Dossow V. Intraoperative Anesthetic Management of Lung Transplantation: Center-Specific Practices and Geographic and Centers Size Differences. Journal of Cardiothoracic and Vascular Anesthesia. PMID 29174123 DOI: 10.1053/j.jvca.2017.05.025 |
0.01 |
|
| 2017 |
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, ... ... Klotz LO, et al. Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162]. Redox Biology. PMID 29107648 DOI: 10.1016/J.Redox.2017.10.001 |
0.01 |
|
| 2017 |
Klotz L. Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes. The Urologic Clinics of North America. 44: 565-574. PMID 29107273 DOI: 10.1016/j.ucl.2017.07.005 |
0.01 |
|
| 2017 |
Kasivisvanathan V, Jichi F, Klotz L, Villers A, Taneja SS, Punwani S, Freeman A, Emberton M, Moore CM. A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol. Bmj Open. 7: e017863. PMID 29025845 DOI: 10.1136/bmjopen-2017-017863 |
0.01 |
|
| 2017 |
Breuer J, Herich S, Schneider-Hohendorf T, Chasan AI, Wettschureck N, Gross CC, Loser K, Zarbock A, Roth J, Klotz L, Wiendl H, Schwab N. Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517735189. PMID 28984166 DOI: 10.1177/1352458517735189 |
0.01 |
|
| 2017 |
Wallis CJD, Klotz L. Prostatectomy versus Observation for Early Prostate Cancer. The New England Journal of Medicine. 377: 1301-2. PMID 28976174 DOI: 10.1056/NEJMc1710384 |
0.01 |
|
| 2017 |
Herold M, Breuer J, Hucke S, Knolle P, Schwab N, Wiendl H, Klotz L. Liver X receptor activation promotes differentiation of regulatory T cells. Plos One. 12: e0184985. PMID 28926619 DOI: 10.1371/journal.pone.0184985 |
0.01 |
|
| 2017 |
Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 28893994 DOI: 10.1073/Pnas.1711233114 |
0.01 |
|
| 2017 |
Schwab N, Schneider-Hohendorf T, Hoyt T, Gross CC, Meuth SG, Klotz L, Foley JF, Wiendl H. Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517728814. PMID 28847222 DOI: 10.1177/1352458517728814 |
0.01 |
|
| 2017 |
Siemens DR, Klotz L, Heidenreich A, Chowdhury S, Villers A, Baron B, van Os S, Hasabou N, Wang F, Lin P, Shore ND. Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration-resistant Prostate Cancer in the TERRAIN Trial. The Journal of Urology. PMID 28827103 DOI: 10.1016/j.juro.2017.08.080 |
0.01 |
|
| 2017 |
Klotz LO, Steinbrenner H. Cellular adaptation to xenobiotics: Interplay between xenosensors, reactive oxygen species and FOXO transcription factors. Redox Biology. 13: 646-654. PMID 28818793 DOI: 10.1016/j.redox.2017.07.015 |
0.01 |
|
| 2017 |
Hazari Z, Potvin G, Cribbs JD, Godwin A, Scott TD, Klotz L. Interest in STEM is contagious for students in biology, chemistry, and physics classes. Science Advances. 3: e1700046. PMID 28808678 DOI: 10.1126/Sciadv.1700046 |
0.01 |
|
| 2017 |
Klotz L. Active Surveillance for Intermediate Risk Prostate Cancer. Current Urology Reports. 18: 80. PMID 28801885 DOI: 10.1007/s11934-017-0726-3 |
0.01 |
|
| 2017 |
Pallauf K, Duckstein N, Hasler M, Klotz LO, Rimbach G. Flavonoids as Putative Inducers of the Transcription Factors Nrf2, FoxO, and PPARγ. Oxidative Medicine and Cellular Longevity. 2017: 4397340. PMID 28761622 DOI: 10.1155/2017/4397340 |
0.01 |
|
| 2017 |
Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple Sclerosis. International Journal of Molecular Sciences. 18. PMID 28708108 DOI: 10.3390/ijms18071526 |
0.01 |
|
| 2017 |
Ruland C, Renken H, Kuzmanov I, Fattahi Mehr A, Schwarte K, Cerina M, Herrmann A, Otte DM, Zimmer A, Schwab N, Meuth SG, Arolt V, Klotz L, Förster I, Scheu S, et al. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain, Behavior, and Immunity. PMID 28642092 DOI: 10.1016/J.Bbi.2017.06.010 |
0.01 |
|
| 2017 |
Wunsch M, Jabari S, Voussen B, Enders M, Srinivasan S, Cossais F, Wedel T, Boettner M, Schwarz A, Weyer L, Göcer O, Schroeter M, Maeurer M, Woenckhaus M, Pollok K, ... ... Klotz L, et al. The enteric nervous system is a potential autoimmune target in multiple sclerosis. Acta Neuropathologica. PMID 28620692 DOI: 10.1007/s00401-017-1742-6 |
0.01 |
|
| 2017 |
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, ... ... Klotz LO, et al. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biology. 13: 94-162. PMID 28577489 DOI: 10.1016/J.Redox.2017.05.007 |
0.01 |
|
| 2017 |
Garisto JD, Klotz L. Active Surveillance for Prostate Cancer: How to Do It Right. Oncology (Williston Park, N.Y.). 31. PMID 28512731 |
0.01 |
|
| 2017 |
Westerman ME, Bhindi B, Choo R, Gettman MT, Karnes RJ, Klotz L, Boorjian SA. Media reporting of ProtecT: a disconnect in information dissemination? Prostate Cancer and Prostatic Diseases. PMID 28462943 DOI: 10.1038/pcan.2017.27 |
0.01 |
|
| 2017 |
Sayyid RK, Dingar D, Fleshner K, Thorburn T, Diamond J, Yao E, Hersey K, Chadwick K, Perlis N, Klotz L, Finelli A, Hamilton R, Kulkarni G, Zlotta A, Fleshner N. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy? Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 11: 118-122. PMID 28458749 DOI: 10.5489/cuaj.4182 |
0.01 |
|
| 2017 |
Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F. Supplementary data: Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 11: E62-E63. PMID 28443152 DOI: 10.5489/Cuaj.4494 |
0.01 |
|
| 2017 |
Klotz L, Breau RH, Collins LL, Gleave ME, Pickles T, Pouliot F, Saad F. Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 11: 16-23. PMID 28443139 DOI: 10.5489/Cuaj.4303 |
0.01 |
|
| 2017 |
Albrecht S, Fleck AK, Kirchberg I, Hucke S, Liebmann M, Klotz L, Kuhlmann T. Activation of FXR pathway does not alter glial cell function. Journal of Neuroinflammation. 14: 66. PMID 28351411 DOI: 10.1186/s12974-017-0833-6 |
0.01 |
|
| 2017 |
Tay KJ, Scheltema MJ, Ahmed HU, Barret E, Coleman JA, Dominguez-Escrig J, Ghai S, Huang J, Jones JS, Klotz LH, Robertson CN, Sanchez-Salas R, Scionti S, Sivaraman A, de la Rosette J, et al. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer and Prostatic Diseases. PMID 28349978 DOI: 10.1038/pcan.2017.8 |
0.01 |
|
| 2017 |
Mascia F, Klotz L, Lerch J, Ahmed MA, Zhang Y, Enz R. CRIP1a inhibits endocytosis of G-protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism. Journal of Neurochemistry. PMID 28295323 DOI: 10.1111/Jnc.14021 |
0.01 |
|
| 2017 |
Schmidt A, Strecker JK, Hucke S, Bruckmann NM, Herold M, Mack M, Diederich K, Schäbitz WR, Wiendl H, Klotz L, Minnerup J. Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke. Stroke. PMID 28292872 DOI: 10.1161/STROKEAHA.116.015577 |
0.01 |
|
| 2017 |
Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure. Nature Reviews. Urology. PMID 28290462 DOI: 10.1038/nrurol.2017.26 |
0.01 |
|
| 2017 |
Bratt O, Hugosson J, Klotz L, Gnanapragasam V. The drama of prostate cancer diagnostics. The Lancet. Oncology. 18: e132. PMID 28271865 DOI: 10.1016/S1470-2045(17)30121-3 |
0.01 |
|
| 2017 |
Klotz L. Active surveillance for low-risk prostate cancer. Current Opinion in Urology. PMID 28267056 DOI: 10.1097/MOU.0000000000000393 |
0.01 |
|
| 2017 |
Tsitsipatis D, Klotz LO, Steinbrenner H. Multifaceted functions of the forkhead box transcription factors FoxO1 and FoxO3 in skin. Biochimica Et Biophysica Acta. PMID 28249743 DOI: 10.1016/j.bbagen.2017.02.027 |
0.01 |
|
| 2017 |
Gross CC, Meyer Zu Hörste G, Schulte-Mecklenbeck A, Klotz L, Meuth SG, Wiendl H. Reply to Liu et al.: Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137888 DOI: 10.1073/pnas.1619059114 |
0.01 |
|
| 2017 |
Limmroth V, Ziemssen T, Lang M, Richter S, Wagner B, Haas J, Schmidt S, Gerbershagen K, Lassek C, Klotz L, Hoffmann O, Albert C, Schuh K, Baier-Ebert M, Wendt G, et al. Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study. Bmc Neurology. 17: 11. PMID 28100182 DOI: 10.1186/s12883-016-0789-7 |
0.01 |
|
| 2017 |
Klotz L, Kibel A. 10-Year Outcomes in Localized Prostate Cancer. The New England Journal of Medicine. 376: 178. PMID 28079329 |
0.01 |
|
| 2016 |
Urban N, Tsitsipatis D, Hausig F, Kreuzer K, Erler K, Stein V, Ristow M, Steinbrenner H, Klotz LO. Non-linear impact of glutathione depletion on C. elegans life span and stress resistance. Redox Biology. 11: 502-515. PMID 28086197 DOI: 10.1016/j.redox.2016.12.003 |
0.01 |
|
| 2016 |
Kuzmanov I, Herrmann AM, Galla HJ, Meuth SG, Wiendl H, Klotz L. An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction. Journal of Visualized Experiments : Jove. PMID 28060303 DOI: 10.3791/54592 |
0.01 |
|
| 2016 |
Mayer MJ, Klotz LH, Venkateswaran V. The effect of metformin use during docetaxel chemotherapy on prostate cancer-specific and overall survival of diabetic castration-resistant prostate cancer patients. The Journal of Urology. PMID 27984108 DOI: 10.1016/j.juro.2016.10.069 |
0.01 |
|
| 2016 |
Dall'Era MA, Klotz L. Active surveillance for intermediate-risk prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 27801900 DOI: 10.1038/pcan.2016.51 |
0.01 |
|
| 2016 |
Richard PO, Alibhai SM, Panzarella T, Klotz L, Komisarenko M, Fleshner NE, Urbach D, Finelli A. The uptake of active surveillance for the management of prostate cancer: A population-based analysis. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 10: E342-E346. PMID 27800064 DOI: 10.5489/Cuaj.4207 |
0.01 |
|
| 2016 |
Richard PO, Alibhai SM, Panzarella T, Klotz L, Komisarenko M, Fleshner NE, Urbach D, Finelli A. The uptake of active surveillance for the management of prostate cancer: A population-based analysis. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 10: 333-338. PMID 27800055 DOI: 10.5489/Cuaj.3684 |
0.01 |
|
| 2016 |
Mykicki N, Herrmann AM, Schwab N, Deenen R, Sparwasser T, Limmer A, Wachsmuth L, Klotz L, Köhrer K, Faber C, Wiendl H, Luger TA, Meuth SG, Loser K. Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. Science Translational Medicine. 8: 362ra146. PMID 27797962 DOI: 10.1126/scitranslmed.aaf8732 |
0.01 |
|
| 2016 |
Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, Klotz L, Arolt V, Wiendl H, Meuth SG, Alferink J. Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 3: e289. PMID 27766281 DOI: 10.1212/NXI.0000000000000289 |
0.01 |
|
| 2016 |
Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, et al. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force. European Urology. PMID 27720532 DOI: 10.1016/J.Eururo.2016.09.041 |
0.01 |
|
| 2016 |
Klotz L, Kuzmanov I, Hucke S, Gross CC, Posevitz V, Dreykluft A, Schulte-Mecklenbeck A, Janoschka C, Lindner M, Herold M, Schwab N, Ludwig-Portugall I, Kurts C, Meuth SG, Kuhlmann T, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27671636 DOI: 10.1073/pnas.1601350113 |
0.01 |
|
| 2016 |
Musunuru HB, Yamamoto T, Klotz L, Ghanem G, Mamedov A, Sethukavalan P, Jethava V, Jain S, Zhang L, Vesprini D, Loblaw A. Active Surveillance in Intermediate-Risk Patients: Survival Outcomes in the Sunnybrook Experience. The Journal of Urology. PMID 27569437 DOI: 10.1016/j.juro.2016.06.102 |
0.01 |
|
| 2016 |
Klotz L, Higano CS. Intermittent Androgen Deprivation Therapy-An Important Treatment Option for Prostate Cancer. Jama Oncology. PMID 27560985 DOI: 10.1001/jamaoncol.2016.3138 |
0.01 |
|
| 2016 |
Zhao F, Olkhov-Mitsel E, van der Kwast T, Sykes J, Zdravic D, Venkateswaran V, Zlotta AR, Loblaw A, Fleshner NE, Klotz L, Vesprini D, Bapat B. Urinary DNA methylation biomarkers for non-invasive prediction of aggressive disease in prostate cancer patients on Active Surveillance. The Journal of Urology. PMID 27545574 DOI: 10.1016/J.Juro.2016.08.081 |
0.01 |
|
| 2016 |
Ramsay E, Mougenot C, Staruch R, Boyes A, Kazem M, Bronskill M, Foster H, Sugar L, Haider M, Klotz L, Chopra R. Evaluation of focal ablation of MRI-defined prostate cancer using MRI-controlled transurethral ultrasound therapy with prostatectomy as the reference standard. The Journal of Urology. PMID 27545572 DOI: 10.1016/J.Juro.2016.06.100 |
0.01 |
|
| 2016 |
Klotz L. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer. Oncology (Williston Park, N.Y.). 30. PMID 27528237 |
0.01 |
|
| 2016 |
Gleave ME, Klotz L. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Con. The Journal of Urology. PMID 27520085 DOI: 10.1016/j.juro.2016.08.010 |
0.01 |
|
| 2016 |
Heidenreich A, Chowdhury S, Klotz L, Siemens DR, Villers A, Ivanescu C, Holmstrom S, Baron B, Wang F, Lin P, Shore ND. Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial. European Urology. PMID 27497762 DOI: 10.1016/j.eururo.2016.07.027 |
0.01 |
|
| 2016 |
Gross CC, Schulte-Mecklenbeck A, Hanning U, Posevitz-Fejfár A, Korsukewitz C, Schwab N, Meuth SG, Wiendl H, Klotz L. Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27481205 DOI: 10.1177/1352458516662726 |
0.01 |
|
| 2016 |
Gleave ME, Klotz L. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression. The Journal of Urology. PMID 27449261 DOI: 10.1016/j.juro.2016.07.075 |
0.01 |
|
| 2016 |
Cher ML, Dhir A, Auffenberg GB, Linsell S, Gao Y, Rosenberg B, Jafri SM, Klotz L, Miller DC, Ghani KR, Bernstein SJ, Montie JE, Lane BR. Appropriateness Criteria for Active Surveillance of Prostate Cancer. The Journal of Urology. PMID 27422298 DOI: 10.1016/j.juro.2016.07.005 |
0.01 |
|
| 2016 |
Hucke S, Herold M, Liebmann M, Freise N, Lindner M, Fleck AK, Zenker S, Thiebes S, Fernandez-Orth J, Buck D, Luessi F, Meuth SG, Zipp F, Hemmer B, Engel DR, ... ... Klotz L, et al. The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion. Acta Neuropathologica. PMID 27383204 DOI: 10.1007/s00401-016-1593-6 |
0.01 |
|
| 2016 |
Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, et al. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. European Urology. PMID 27349615 DOI: 10.1016/j.eururo.2016.06.011 |
0.01 |
|
| 2016 |
Vandersluis AD, Guy DE, Klotz LH, Fleshner NE, Kiss A, Parker C, Venkateswaran V. The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts. Prostate Cancer and Prostatic Diseases. PMID 27349497 DOI: 10.1038/pcan.2016.22 |
0.01 |
|
| 2016 |
Göbel K, Pankratz S, Asaridou CM, Herrmann AM, Bittner S, Merker M, Ruck T, Glumm S, Langhauser F, Kraft P, Krug TF, Breuer J, Herold M, Gross CC, Beckmann D, ... ... Klotz L, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nature Communications. 7: 11626. PMID 27188843 DOI: 10.1038/ncomms11626 |
0.01 |
|
| 2016 |
Klotz L, Evans CP. Surgery Provides Better Oncologic Outcomes than Radiation for the Treatment of Prostate Cancer. The Journal of Urology. PMID 27164513 DOI: 10.1016/j.juro.2016.05.008 |
0.01 |
|
| 2016 |
Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, Schwab N, Schneider-Hohendorf T, Herich S, Held K, Konjević M, Hartwig M, Dornmair K, Hohlfeld R, Ziemssen T, Klotz L, et al. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Proceedings of the National Academy of Sciences of the United States of America. 113: E2973-82. PMID 27162345 DOI: 10.1073/pnas.1524924113 |
0.01 |
|
| 2016 |
Speckmann B, Steinbrenner H, Grune T, Klotz LO. Peroxynitrite: From interception to signaling. Archives of Biochemistry and Biophysics. 595: 153-60. PMID 27095233 DOI: 10.1016/j.abb.2015.06.022 |
0.01 |
|
| 2016 |
Steinbrenner H, Speckmann B, Klotz LO. Selenoproteins: Antioxidant selenoenzymes and beyond. Archives of Biochemistry and Biophysics. 595: 113-9. PMID 27095226 DOI: 10.1016/j.abb.2015.06.024 |
0.01 |
|
| 2016 |
Iversen P, Damber JE, Malmberg A, Persson BE, Klotz L. Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials. Therapeutic Advances in Urology. 8: 75-82. PMID 27034720 DOI: 10.1177/1756287215621471 |
0.01 |
|
| 2016 |
Ruck T, Afzali AM, Lukat KF, Eveslage M, Gross CC, Pfeuffer S, Bittner S, Klotz L, Melzer N, Wiendl H, Meuth SG. ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential. Bmc Neurology. 16: 34. PMID 26966029 DOI: 10.1186/s12883-016-0556-9 |
0.01 |
|
| 2016 |
Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, et al. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt. PMID 26927677 DOI: 10.1007/S00115-016-0077-1 |
0.01 |
|
| 2016 |
Urbánek P, Klotz LO. Posttranscriptional regulation of FOXO expression: microRNAs and beyond. British Journal of Pharmacology. PMID 26920226 DOI: 10.1111/bph.13471 |
0.01 |
|
| 2016 |
Bhatt JR, Klotz L. Overtreatment in cancer - is it a problem? Expert Opinion On Pharmacotherapy. 17: 1-5. PMID 26789721 DOI: 10.1517/14656566.2016.1115481 |
0.01 |
|
| 2016 |
Shore ND, Chowdhury S, Villers A, Klotz L, Siemens DR, Phung, van Os S, Hasabou N, Wang F, Bhattacharya S, Heidenreich A. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. The Lancet. Oncology. PMID 26774508 DOI: 10.1016/S1470-2045(15)00518-5 |
0.01 |
|
| 2016 |
Gross CC, Schulte-Mecklenbeck A, Klinsing S, Posevitz-Fejfár A, Wiendl H, Klotz L. Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation. 3: e183. PMID 26767188 DOI: 10.1212/NXI.0000000000000183 |
0.01 |
|
| 2016 |
Klotz LV, Morresi-Hauf A, Hatz RA, Lindner M. Vascular Leiomyoma of the Pulmonary Artery. The Annals of Thoracic Surgery. 101: 342-4. PMID 26694272 DOI: 10.1016/j.athoracsur.2015.02.113 |
0.01 |
|
| 2016 |
Hucke S, Wiendl H, Klotz L. Implications of dietary salt intake for multiple sclerosis pathogenesis. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 133-9. PMID 26447064 DOI: 10.1177/1352458515609431 |
0.01 |
|
| 2016 |
Klotz L. Current status of clinical trials in active surveillance The Prostate Cancer Dilemma: Selecting Patients For Active Surveillance, Focal Ablation and Definitive Therapy. 141-152. DOI: 10.1007/978-3-319-21485-6_10 |
0.01 |
|
| 2015 |
Klotz L. Active surveillance and focal therapy for low-intermediate risk prostate cancer. Translational Andrology and Urology. 4: 342-54. PMID 26816834 DOI: 10.3978/j.issn.2223-4683.2015.06.03 |
0.01 |
|
| 2015 |
Yamamoto T, Musunuru B, Vesprini D, Zhang L, Ghanem G, Loblaw A, Klotz L. Metastatic Prostate Cancer in Men Initially Managed with Active Surveillance. The Journal of Urology. PMID 26707510 DOI: 10.1016/j.juro.2015.11.075 |
0.01 |
|
| 2015 |
Kehrer JP, Klotz LO. Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health. Critical Reviews in Toxicology. 45: 765-98. PMID 26610815 DOI: 10.3109/10408444.2015.1074159 |
0.01 |
|
| 2015 |
Klotz L. Editorial Comment. Urology. 86: 996. PMID 26590040 DOI: 10.1016/j.urology.2015.07.043 |
0.01 |
|
| 2015 |
Hucke S, Eschborn M, Liebmann M, Herold M, Freise N, Engbers A, Ehling P, Meuth SG, Roth J, Kuhlmann T, Wiendl H, Klotz L. Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. Journal of Autoimmunity. PMID 26584738 DOI: 10.1016/j.jaut.2015.11.001 |
0.01 |
|
| 2015 |
Wallis CJ, Mahar A, Cheung P, Herschorn S, Klotz LH, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men. European Urology. PMID 26572707 DOI: 10.1016/J.Eururo.2015.10.043 |
0.01 |
|
| 2015 |
Ziemssen T, Albrecht H, Haas J, Klotz L, Lang M, Lassek C, Schmidt S, Tackenberg B, Cornelissen C. 36 Months Pangaea: A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A749. PMID 26534196 DOI: 10.1016/j.jval.2015.09.2894 |
0.01 |
|
| 2015 |
Nam RK, Amemiya Y, Benatar T, Wallis CJ, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study. Journal of Cancer. 6: 1160-71. PMID 26516365 DOI: 10.7150/Jca.13397 |
0.01 |
|
| 2015 |
Klotz L. Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer. Expert Opinion On Drug Metabolism & Toxicology. 11: 1795-802. PMID 26513436 DOI: 10.1517/17425255.2015.1085506 |
0.01 |
|
| 2015 |
Risebro CA, Vieira JM, Klotz L, Riley PR. Characterisation of the human embryonic and foetal epicardium during heart development. Development (Cambridge, England). 142: 3630-6. PMID 26395486 DOI: 10.1242/dev.127621 |
0.01 |
|
| 2015 |
Klotz LV, Gesierich W, Schott-Hildebrand S, Hatz RA, Lindner M. Endobronchial closure of bronchopleural fistula using Amplatzer device. Journal of Thoracic Disease. 7: 1478-82. PMID 26380774 DOI: 10.3978/j.issn.2072-1439.2015.08.25 |
0.01 |
|
| 2015 |
Herold M, Posevitz V, Chudyka D, Hucke S, Groß C, Kurth F, Leder C, Loser K, Kurts C, Knolle P, Klotz L, Wiendl H. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway. Journal of Immunology (Baltimore, Md. : 1950). PMID 26378076 DOI: 10.4049/jimmunol.1402746 |
0.01 |
|
| 2015 |
Klotz LV, Lindner M, Hatz RA. [Pulmonary Tuberculosis - Is Surgery still Necessary?]. Zentralblatt FüR Chirurgie. 140: S36-42. PMID 26351762 DOI: 10.1055/s-0035-1546249 |
0.01 |
|
| 2015 |
Gliem M, Klotz L, van Rooijen N, Hartung HP, Jander S. Hyperglycemia and PPARγ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic Stroke. Stroke; a Journal of Cerebral Circulation. 46: 2935-42. PMID 26337971 DOI: 10.1161/STROKEAHA.115.010557 |
0.01 |
|
| 2015 |
Kolber P, Luessi F, Meuth SG, Klotz L, Korn T, Trebst C, Tackenberg B, Kieseier B, Kümpfel T, Fleischer V, Tumani H, Wildemann B, Lang M, Flachenecker P, Meier U, et al. [Current aspects of therapy conversion for multiple sclerosis]. Der Nervenarzt. 86: 1236-47. PMID 26269289 DOI: 10.1007/S00115-015-4368-8 |
0.01 |
|
| 2015 |
Morash C, Tey R, Agbassi C, Klotz L, McGowan T, Srigley J, Evans A. Active surveillance for the management of localized prostate cancer: Guideline recommendations. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 9: 171-8. PMID 26225165 DOI: 10.5489/cuaj.2806 |
0.01 |
|
| 2015 |
Mayer MJ, Klotz LH, Venkateswaran V. Metformin and prostate cancer stem cells: a novel therapeutic target. Prostate Cancer and Prostatic Diseases. PMID 26215782 DOI: 10.1038/pcan.2015.35 |
0.01 |
|
| 2015 |
Simm A, Klotz LO. Stress and biological aging: A double-edged sword. Zeitschrift FüR Gerontologie Und Geriatrie. 48: 505-10. PMID 26206469 DOI: 10.1007/s00391-015-0928-6 |
0.01 |
|
| 2015 |
Klotz LO, Sánchez-Ramos C, Prieto-Arroyo I, Urbánek P, Steinbrenner H, Monsalve M. Redox regulation of FoxO transcription factors. Redox Biology. 6: 51-72. PMID 26184557 DOI: 10.1016/j.redox.2015.06.019 |
0.01 |
|
| 2015 |
Sasaki H, Klotz LH, Sugar LM, Kiss A, Venkateswaran V. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells. Biochemical and Biophysical Research Communications. 464: 848-54. PMID 26182875 DOI: 10.1016/j.bbrc.2015.07.050 |
0.01 |
|
| 2015 |
Klotz L, Grützke B, Eveslage M, Deppe M, Gross CC, Kirstein L, Posevitz-Fejfar A, Schneider-Hohendorf T, Schwab N, Meuth SG, Wiendl H. Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor). Bmc Neurology. 15: 96. PMID 26099927 DOI: 10.1186/s12883-015-0354-9 |
0.01 |
|
| 2015 |
van der Poel H, Klotz L, Stief CG. Management of low- and intermediate-risk prostate cancer. World Journal of Urology. 33: 905-6. PMID 26091565 DOI: 10.1007/s00345-015-1618-0 |
0.01 |
|
| 2015 |
Klotz LC. Danger of Potential-Pandemic-Pathogen Research Enterprises. Mbio. 6: e00815. PMID 26081636 DOI: 10.1128/mBio.00815-15 |
0.01 |
|
| 2015 |
Venier NA, Yamamoto T, Sugar LM, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model. The Prostate. 75: 1300-11. PMID 26047020 DOI: 10.1002/pros.23013 |
0.01 |
|
| 2015 |
van der Poel H, Klotz L, Andriole G, Azzouzi AR, Bjartell A, Cussenot O, Hamdy F, Graefen M, Palma P, Rivera AR, Stief CG. Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers. World Journal of Urology. 33: 907-16. PMID 26037891 DOI: 10.1007/s00345-015-1603-7 |
0.01 |
|
| 2015 |
Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dubé KN, Bollini S, Matsuzaki F, Carr CA, Riley PR. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 522: 62-7. PMID 25992544 DOI: 10.1038/nature14483 |
0.01 |
|
| 2015 |
Mora BC, Fleshner NE, Klotz LH, Venkateswaran V. The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro. Lipid Insights. 8: 11-9. PMID 25987846 DOI: 10.4137/LPI.S23135 |
0.01 |
|
| 2015 |
Klotz LV, Clevert DA, Scheckinger S, Strieth S, Eichhorn ME. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy. Anticancer Research. 35: 2571-6. PMID 25964532 |
0.01 |
|
| 2015 |
Preisner A, Albrecht S, Cui QL, Hucke S, Ghelman J, Hartmann C, Taketo MM, Antel J, Klotz L, Kuhlmann T. Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination. Acta Neuropathologica. PMID 25943886 DOI: 10.1007/S00401-015-1426-Z |
0.01 |
|
| 2015 |
Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, Rosario DJ, Skolarus TA, Penson DF. Survivorship and improving quality of life in men with prostate cancer. European Urology. 68: 374-83. PMID 25941049 DOI: 10.1016/j.eururo.2015.04.023 |
0.01 |
|
| 2015 |
Klotz L. Testosterone therapy and prostate cancer-safety concerns are well founded Nature Reviews Urology. 12: 48-54. PMID 25563848 DOI: 10.1038/nrurol.2014.338 |
0.01 |
|
| 2015 |
Klotz L. Defining 'progression' and triggers for curative intervention during active surveillance Current Opinion in Urology. 25: 258-266. DOI: 10.1097/MOU.0000000000000158 |
0.01 |
|
| 2015 |
Klotz L. Active surveillance for prostate cancer: Debate over the application, not the concept European Urology. 67: 1006-1008. DOI: 10.1016/j.eururo.2015.01.007 |
0.01 |
|
| 2015 |
Klotz L. Active Surveillance: Rationale, Patient Selection, Follow-up, and Outcomes Prostate Cancer: Science and Clinical Practice: Second Edition. 215-223. DOI: 10.1016/B978-0-12-800077-9.00025-6 |
0.01 |
|
| 2015 |
Klotz L. News from research Aktuelle Neurologie. 42: 426-427. |
0.01 |
|
| 2014 |
Urban N, Tsitsipatis D, Gille A, Hamann I, Hou X, Klotz LO. Modulation of cellular thiol status affects FoxO activity and life span. Free Radical Biology & Medicine. 75: S53. PMID 26461409 DOI: 10.1016/j.freeradbiomed.2014.10.826 |
0.01 |
|
| 2014 |
Klotz L. Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment Evidence-Based Medicine. 19: 40. PMID 23990529 DOI: 10.1136/eb-2013-101481 |
0.01 |
|
| 2013 |
Vesprini D, Mamedov A, Loblaw DA, Klotz L. Gleason upgrading with time in a large, active surveillance cohort with long-term follow-up. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1. PMID 28137139 DOI: 10.1200/jco.2013.31.6_suppl.1 |
0.01 |
|
| 2013 |
Nilsson J, Klotz L, Payne H, van der Meulen E, Persson BE, Olesen TK, Beckman J. Comparision of the risk of cardiovascular events and death in patients treated with degarelix compared with LHRH agonists. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 42. PMID 28137002 DOI: 10.1200/jco.2013.31.6_suppl.42 |
0.01 |
|
| 2013 |
Klotz L. Intermittent androgen deprivation therapy: Clarity from confusion European Urology. 64: 731-733. PMID 23866956 DOI: 10.1016/j.eururo.2013.06.038 |
0.01 |
|
| 2013 |
Klotz L. Intermittent versus continuous androgen deprivation therapy in advanced prostate cancer Current Urology Reports. 14: 159-167. PMID 23700095 DOI: 10.1007/s11934-013-0325-x |
0.01 |
|
| 2013 |
Klotz L. Prostate cancer overdiagnosis and overtreatment Current Opinion in Endocrinology, Diabetes and Obesity. 20: 204-209. PMID 23609043 DOI: 10.1097/MED.0b013e328360332a |
0.01 |
|
| 2013 |
Klotz L. Active surveillance: Patient selection Current Opinion in Urology. 23: 239-244. PMID 23548978 DOI: 10.1097/MOU.0b013e32835f8f6b |
0.01 |
|
| 2013 |
Klotz L. Active surveillance: Current and future directions Current Opinion in Urology. 23: 237-238. PMID 23548977 DOI: 10.1097/MOU.0b013e32835f97e9 |
0.01 |
|
| 2013 |
Klotz L. Active surveillance, quality of life, and cancer-related anxiety European Urology. 64: 37-39. PMID 23433806 DOI: 10.1016/j.eururo.2013.01.023 |
0.01 |
|
| 2013 |
Klotz L. Active surveillance for prostate cancer: Overview and update Current Treatment Options in Oncology. 14: 97-108. PMID 23318986 DOI: 10.1007/s11864-012-0221-5 |
0.01 |
|
| 2013 |
Klotz L. Strengthening evidence for active surveillance for prostate cancer European Urology. 63: 108-110. PMID 23122665 DOI: 10.1016/j.eururo.2012.10.018 |
0.01 |
|
| 2013 |
Klotz L. Re: Editorial comment on focal therapy for localised unifocal and multifocal prostate cancer: A prospective development study (Lancet Oncol 2012; 13: 622-632) Journal of Urology. 189: 1601. DOI: 10.1016/j.juro.2012.11.087 |
0.01 |
|
| 2013 |
Klotz L. Active surveillance not only reduces morbidity, It saves lives Oncology (United States). 27. |
0.01 |
|
| 2012 |
Margel D, Yap S, Lawrentschuk N, Klotz L, Haider MA, Finelli A, Zlotta A, Trachtenberg J, Fleshner NE. Impact of multiparametric endorectal coil prostate MRI on disease reclassification among active surveillance candidates: A prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 30. PMID 28142908 DOI: 10.1200/jco.2012.30.5_suppl.30 |
0.01 |
|
| 2012 |
Chiang AS, Loblaw DA, Jethava V, Sethukavalan P, Zhang L, Vesprini D, Mamedov A, Nam R, Klotz L. Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 14. PMID 28142893 DOI: 10.1200/jco.2012.30.5_suppl.14 |
0.01 |
|
| 2012 |
Margel D, Yap S, Lawrentschuk N, Klotz L, Haider MA, Finelli A, Zlotta A, Trachtenberg J, Fleshner NE. Impact of multiparametric endorectal coil prostate MRI on disease reclassification among active surveillance candidates: A prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 30. PMID 27967849 DOI: 10.1200/Jco.2012.30.5_Suppl.30 |
0.01 |
|
| 2012 |
Chiang AS, Loblaw DA, Jethava V, Sethukavalan P, Zhang L, Vesprini D, Mamedov A, Nam R, Klotz L. Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 14. PMID 27967834 DOI: 10.1200/jco.2012.30.5_suppl.14 |
0.01 |
|
| 2012 |
Klotz L. Active surveillance: The canadian experience with an "Inclusive approach" Journal of the National Cancer Institute - Monographs. 234-241. PMID 23271779 DOI: 10.1093/jncimonographs/lgs042 |
0.01 |
|
| 2012 |
Klotz L. Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes Current Urology Reports. 13: 153-159. PMID 22477615 DOI: 10.1007/s11934-012-0242-4 |
0.01 |
|
| 2012 |
Klotz L. Cancer overdiagnosis and overtreatment Current Opinion in Urology. 22: 203-209. PMID 22472510 DOI: 10.1097/MOU.0b013e32835259aa |
0.01 |
|
| 2012 |
Klotz L. Publishing in Urology: My 20-year journey Journal of the Canadian Urological Association. 6: 223. DOI: 10.5489/cuaj.12229 |
0.01 |
|
| 2012 |
Klotz LH. Everything is in the location: Biopsies prostate and MRI Journal of the Canadian Urological Association. 6: 81. DOI: 10.5489/cuaj.12071 |
0.01 |
|
| 2012 |
Klotz LH. Location, location, location: Prostate biopsies and MRIs Journal of the Canadian Urological Association. 6: 79. DOI: 10.5489/cuaj.12070 |
0.01 |
|
| 2012 |
Klotz L. Active surveillance for low-risk prostate cancer F1000 Medicine Reports. 4. DOI: 10.3410/M4-16 |
0.01 |
|
| 2012 |
Klotz L. Active surveillance for favorable risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes Management of Prostate Cancer: a Multidisciplinary Approach. 85-91. DOI: 10.1007/978-3-642-27597-5_7 |
0.01 |
|
| 2011 |
Crook JM, O'Callaghan CJ, Ding K, Duncan G, Dearnaley DP, Higano CS, Horwitz EM, Frymire E, Malone S, Chin J, Nabid A, Warde PR, Corbett TB, Angyalfi S, Goldenberg SL, ... ... Klotz L, et al. A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4514. PMID 28023453 DOI: 10.1200/Jco.2011.29.15_Suppl.4514 |
0.01 |
|
| 2011 |
Jethava V, Vesprini D, Loblaw DA, Mamedov A, Nam R, Klotz L. A review of radical prostatectomy outcomes in active surveillance patients-The Sunnybrook experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 104. PMID 27968687 DOI: 10.1200/jco.2011.29.7_suppl.104 |
0.01 |
|
| 2011 |
Smith MR, Klotz L, van der Meulen E, Colli E, Tanko LB. Association of baseline risk factors with cardiovascular (CV) events during long-term degarelix therapy in men with prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 190. PMID 27968474 DOI: 10.1200/jco.2011.29.7_suppl.190 |
0.01 |
|
| 2011 |
Klotz L, O'Callaghan CJ, Ding K, Dearnaley DP, Higano CS, Horwitz EM, Malone S, Goldenberg SL, Gospodarowicz MK, Crook JM. A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3. PMID 27968424 DOI: 10.1200/jco.2011.29.7_suppl.3 |
0.01 |
|
| 2011 |
Klotz L, Venier N, Vandersluis A, Besla R, Fleshner N, Pollak MN, Venkateswaran V, Colquhoun AJ. Utilizing metformin to enhance the efficacy of androgen-deprivation therapy in the treatment of prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 22. PMID 27968385 DOI: 10.1200/jco.2011.29.7_suppl.22 |
0.01 |
|
| 2011 |
Klotz L, Venier N, Colquhoun AJ, Sasaki H, Loblaw DA, Fleshner N, Venkateswaran V. Capsaicin, a novel radiosensitizer, acts via a TRPV6 mediated phenomenon. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 23. PMID 27968384 DOI: 10.1200/jco.2011.29.7_suppl.23 |
0.01 |
|
| 2011 |
Klotz L, Venier N, Vandersluis A, Besla R, Fleshner N, Pollak MN, Venkateswaran V, Colquhoun AJ. Utilizing metformin as a radiosensitizing agent in the treatment of prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 89. PMID 27968368 DOI: 10.1200/jco.2011.29.7_suppl.89 |
0.01 |
|
| 2011 |
Klotz L. Active surveillance for prostate cancer: A review Archivos Espanoles De Urologia. 64: 806-813. PMID 22052761 DOI: 10.1007/s11934-010-0110-z |
0.01 |
|
| 2011 |
Klotz L. Re: Delay of surgery in men with low risk prostate cancer Journal of Urology. 186: 2505. PMID 22033446 DOI: 10.1016/j.juro.2011.07.117 |
0.01 |
|
| 2011 |
Klotz L. Active surveillance for favorable risk prostate cancer: Rationale, results, and vis a vis focal therapy role Minerva Urologica E Nefrologica. 63: 145-153. PMID 21623332 |
0.01 |
|
| 2011 |
Klotz LH. USPSTF and FDA: PSA and 5ARIs Journal of the Canadian Urological Association. 5: 373-374. DOI: 10.5489/cuaj.11274 |
0.01 |
|
| 2011 |
Klotz LH. The decline and fall of RCTs Journal of the Canadian Urological Association. 5: 231. DOI: 10.5489/cuaj.11149 |
0.01 |
|
| 2011 |
Klotz LH. JAUC met en œuvre Les "sorties prématurées" Journal of the Canadian Urological Association. 5: 9. DOI: 10.5489/cuaj.11021 |
0.01 |
|
| 2011 |
Klotz LH. CUAJ implements early releases Journal of the Canadian Urological Association. 5: 7. DOI: 10.5489/cuaj.11020 |
0.01 |
|
| 2011 |
Klotz L. Cognitive biases in energy decisions during the planning, design, and construction of commercial buildings in the United States: An analytical framework and research needs Energy Efficiency. 4: 271-284. DOI: 10.1007/S12053-010-9089-Z |
0.01 |
|
| 2011 |
Klotz L. Ben Jonson's legal imagination in Volpone Sel - Studies in English Literature. 51: 385-408. |
0.01 |
|
| 2010 |
Klotz LK. Hope in relation to nursing interventions for HIV-infected patients and their significant others Journal of the Association of Nurses in Aids Care. 21: 345-355. PMID 20347344 DOI: 10.1016/j.jana.2010.01.001 |
0.01 |
|
| 2010 |
Klotz L. Re: Effect of dutasteride on the risk of prostate cancer European Urology. 58: 313. DOI: 10.1016/j.eururo.2010.05.017 |
0.01 |
|
| 2010 |
Klotz L. La MFP dans l'urologie canadienne Journal of the Canadian Urological Association. 4: 84. |
0.01 |
|
| 2010 |
Klotz L. Utiliser efficacement les lignes directrices Journal of the Canadian Urological Association. 4: 8. |
0.01 |
|
| 2010 |
Klotz L. EBM in Canadian urology Journal of the Canadian Urological Association. 4: 83. |
0.01 |
|
| 2010 |
Klotz L. Using consensus guidelines effectively Journal of the Canadian Urological Association. 4: 7. |
0.01 |
|
| 2010 |
Klotz LH. MRI and prostate cancer: Towards new horizons Journal of the Canadian Urological Association. 4: 229-230. |
0.01 |
|
| 2010 |
Klotz LH. An unsung Canadian hero! Journal of the Canadian Urological Association. 4: 371. |
0.01 |
|
| 2010 |
Klotz LH. Améliorer la qualité des soins aux patients Journal of the Canadian Urological Association. 4: 301. |
0.01 |
|
| 2010 |
Klotz LH. Improving quality of care Journal of the Canadian Urological Association. 4: 299. |
0.01 |
|
| 2010 |
Klotz LH. Un nouveau héros canadien! Journal of the Canadian Urological Association. 4: 372. |
0.01 |
|
| 2010 |
Klotz LH. MRI and prostate cancer: The next frontier Journal of the Canadian Urological Association. 4: 227-228. |
0.01 |
|
| 2010 |
Klotz L. Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery Current Oncology. 17: 4. |
0.01 |
|
| 2009 |
Stadler WM, Lerner SP, Groshen S, Stein JP, Skinner DG, Raghavan D, Steinberg GD, Wood D, Klotz LH, Hall MC, Cote R. Randomized trial of p53 targeted adjuvant therapy for patients (pts) with organ- confined node-negative urothelial bladder cancer (UBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5017. PMID 27962900 DOI: 10.1200/jco.2009.27.15_suppl.5017 |
0.01 |
|
| 2009 |
Klotz L. Degarelix acetate for the treatment of prostate cancer Drugs of Today. 45: 725-730. PMID 20069136 DOI: 1396674/dot.2009.45.10.1417873 |
0.01 |
|
| 2009 |
Klotz L. Active Surveillance for Favorable Risk Prostate Cancer Journal of Urology. 182: 2565-2566. PMID 19836767 DOI: 10.1016/j.juro.2009.09.038 |
0.01 |
|
| 2009 |
Klotz L. Response to the article by J.E. Montie, Screen detected, low volume prostate cancer: The case for active treatment. Urol Oncol 2008;26:511-515 Urologic Oncology: Seminars and Original Investigations. 27: 454. PMID 19573778 DOI: 10.1016/j.urolonc.2009.03.010 |
0.01 |
|
| 2009 |
Klotz L. The future of urologic oncology and surgeon-scientists: Proceedings of the World Urologic Oncology Federation, September 2007 Urologic Oncology: Seminars and Original Investigations. 27: 117. PMID 19285217 DOI: 10.1016/j.urolonc.2008.09.028 |
0.01 |
|
| 2009 |
Klotz L. Editorial: The editor is back Journal of the Canadian Urological Association. 3: 277-278. |
0.01 |
|
| 2008 |
Klotz L. Active surveillance for prostate cancer: Trials and tribulations World Journal of Urology. 26: 437-442. PMID 18813934 DOI: 10.1007/s00345-008-0330-8 |
0.01 |
|
| 2008 |
Klotz L. What is the best approach for screen-detected low volume cancers?-The case for observation Urologic Oncology: Seminars and Original Investigations. 26: 495-499. PMID 18774462 DOI: 10.1016/j.urolonc.2008.03.003 |
0.01 |
|
| 2008 |
Klotz L. Response to Epstein's commentary Biosecurity and Bioterrorism. 6: 108-113. PMID 18386977 DOI: 10.1089/bsp.2008.0005 |
0.01 |
|
| 2008 |
Klotz L. Active Surveillance for Favorable Risk Prostate Cancer: What Are the Results, and How Safe Is It? Seminars in Radiation Oncology. 18: 2-6. PMID 18082582 DOI: 10.1016/j.semradonc.2007.09.001 |
0.01 |
|
| 2008 |
Klotz L. Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention Nature Clinical Practice Urology. 5: 2-3. PMID 18043601 DOI: 10.1038/ncpuro0993 |
0.01 |
|
| 2008 |
Klotz L. Nomogram for predicting survival in men with clinically localized prostate cancer who do not undergo definitive therapy: Commentary Nature Clinical Practice Urology. 5: 362-363. DOI: 10.1038/ncpuro1131 |
0.01 |
|
| 2008 |
Klotz L. Editorial: Indexed!!! Journal of the Canadian Urological Association. 2. |
0.01 |
|
| 2008 |
Klotz L. Editorial: Indexation: Not quite yet Journal of the Canadian Urological Association. 2. |
0.01 |
|
| 2008 |
Klotz L. Editorial: The impact of surgical complexities Journal of the Canadian Urological Association. 2: 9-11. |
0.01 |
|
| 2007 |
Klotz L. Casting a wider net for countermeasure R&D funding decisions Biosecurity and Bioterrorism. 5: 313-318. PMID 18081491 DOI: 10.1089/bsp.2007.0026 |
0.01 |
|
| 2007 |
Klotz L. Active surveillance for favorable risk prostate cancer: Rationale, risks, and results Urologic Oncology: Seminars and Original Investigations. 25: 505-509. PMID 18047961 DOI: 10.1016/j.urolonc.2007.05.021 |
0.01 |
|
| 2007 |
Klotz L. Active surveillance for favorable-risk prostate cancer: Who, how and why? Nature Clinical Practice Oncology. 4: 692-698. PMID 18037873 DOI: 10.1038/ncponc0966 |
0.01 |
|
| 2007 |
Klotz L. Active surveillance for favorable-risk prostate cancer: What are the results and how safe is it? Current Urology Reports. 8: 341-344. PMID 17880830 DOI: 10.1007/s11934-007-0027-3 |
0.01 |
|
| 2007 |
Klotz L. Point: Active surveillance for favorable risk prostate cancer Jnccn Journal of the National Comprehensive Cancer Network. 5: 693-698. PMID 17692173 |
0.01 |
|
| 2007 |
Klotz L. Some remarks on an interpolation problem of A. M. Yaglom Theory of Probability and Its Applications. 51: 342-350. DOI: 10.1137/S0040585X97982402 |
0.01 |
|
| 2007 |
Klotz L. World Urologic Oncology Federation (WUOF): History, mandate, and progress Urologic Oncology: Seminars and Original Investigations. 25: 186-187. DOI: 10.1016/j.urolonc.2007.03.008 |
0.01 |
|
| 2007 |
Klotz L. The uses of error Journal of the Canadian Urological Association. 1: 235. |
0.01 |
|
| 2007 |
Klotz L. The robotic radical prostatectomy: Fad or wave of the future? Journal of the Canadian Urological Association. 1: 89. |
0.01 |
|
| 2007 |
Klotz L. Robotic radical prostatectomy: Fools rush in, or the early bird gets the worm? Journal of the Canadian Urological Association. 1: 87. |
0.01 |
|
| 2007 |
Klotz L. Health advocacy in urology training Journal of the Canadian Urological Association. 1: 356. |
0.01 |
|
| 2007 |
Klotz L. A new journal and new opportunities Journal of the Canadian Urological Association. 1: 9. |
0.01 |
|
| 2007 |
Klotz L. Usefulness of mistakes Journal of the Canadian Urological Association. 1: 237. |
0.01 |
|
| 2007 |
Klotz L. Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists Journal of the Canadian Urological Association. 1. |
0.01 |
|
| 2006 |
Klotz L. Active surveillance versus radical treatment for favorable-risk localized prostate cancer Current Treatment Options in Oncology. 7: 355-362. PMID 16904052 DOI: 10.1007/s11864-006-0003-z |
0.01 |
|
| 2006 |
Klotz LH. PSA recurrence: definitions, PSA kinetics, and identifying patients at risk The Canadian Journal of Urology.. 13: 43-47. PMID 16672128 |
0.01 |
|
| 2006 |
Klotz L. Combined Androgen Blockade: An Update Urologic Clinics of North America. 33: 161-166. PMID 16631454 DOI: 10.1016/j.ucl.2005.12.001 |
0.01 |
|
| 2006 |
Klotz LH. Androgen replacement and/or 5 alpha reductase inhibitors in aging men The Canadian Journal of Urology. 13: 44-45. PMID 16526981 |
0.01 |
|
| 2006 |
Klotz LH. Out of country health care The Canadian Journal of Urology.. 13: 2947. PMID 16515748 |
0.01 |
|
| 2006 |
Klotz L. Active surveillance with selective delayed intervention for favorable risk prostate cancer Urologic Oncology: Seminars and Original Investigations. 24: 46-50. PMID 16414494 DOI: 10.1016/j.urolonc.2005.07.002 |
0.01 |
|
| 2006 |
Klotz L. Active surveillance for genitourinary cancer: An overview Urologic Oncology: Seminars and Original Investigations. 24: 44-45. PMID 16414493 DOI: 10.1016/j.urolonc.2005.07.001 |
0.01 |
|
| 2005 |
Klotz L. Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer Nature Clinical Practice Urology. 2: 136-142. PMID 16474710 DOI: 10.1038/ncpuro0124 |
0.01 |
|
| 2005 |
Klotz LH. Seeing is believing: image guided therapy in urology The Canadian Journal of Urology. 12: 2870. PMID 16401371 |
0.01 |
|
| 2005 |
Klotz L. Active surveillance for prostate cancer: For whom? Journal of Clinical Oncology. 23: 8165-8169. PMID 16278468 DOI: 10.1200/JCO.2005.03.3134 |
0.01 |
|
| 2005 |
Klotz LH. Heuristics in education and clinical practice in urology The Canadian Journal of Urology. 12: 2806. PMID 16274515 |
0.01 |
|
| 2005 |
Klotz L. How (not) to communicate new scientific information: A memoir of the famous Brindley lecture Bju International. 96: 956-957. PMID 16225508 DOI: 10.1111/j.1464-410X.2005.05797.x |
0.01 |
|
| 2005 |
Klotz LH. Impact of the Chaouli decision The Canadian Journal of Urology. 12: 2726. PMID 16197595 |
0.01 |
|
| 2005 |
Klotz LH. Active surveillance for good risk prostate cancer: rationale, method, and results The Canadian Journal of Urology. 12: 21-24. PMID 16018828 |
0.01 |
|
| 2005 |
Klotz LH. International regional working groups on prostate cancer: results of consensus development The Canadian Journal of Urology. 12: 86-91. PMID 15780174 |
0.01 |
|
| 2005 |
Klotz LH. Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive disease The Canadian Journal of Urology. 12. PMID 15780167 |
0.01 |
|
| 2005 |
Klotz LH. Live donor nephrectomy The Canadian Journal of Urology. 12: 2506. PMID 15777485 |
0.01 |
|
| 2005 |
Klotz L. Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer European Urology. 47: 16-21. PMID 15582244 DOI: 10.1016/j.eururo.2004.09.010 |
0.01 |
|
| 2005 |
Klotz L. Can clinically localized prostate cancer be managed conservatively? Nature Clinical Practice Urology. 2: 416-417. DOI: 10.1038/ncpuro0292 |
0.01 |
|
| 2005 |
Klotz L. Optimising hormone therapy in localised and early disease European Urology, Supplements. 4: 12-20. DOI: 10.1016/j.eursup.2005.08.002 |
0.01 |
|
| 2005 |
Klotz L. Bicalutamide combination therapy for advanced prostate cancer American Journal of Urology Review. 3. |
0.01 |
|
| 2004 |
Klotz LH, Schellhammer PF, Carroll KJ. Bicalutamide combination therapy versus castration alone: A combined analysis of historical data. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4634. PMID 28015770 DOI: 10.1200/jco.2004.22.14_suppl.4634 |
0.01 |
|
| 2004 |
Gleave ME, Chi KN, Goldenberg L, Chin J, Winquist E, Klotz L, Saad F, Trachtenberg J. Multicentre phase II trial of combination neoadjuvant hormone therapy and weekly docetaxel prior to radical prostatectomy in high risk localized prostate cancer (CUOG-P01a). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4635. PMID 28015769 DOI: 10.1200/Jco.2004.22.14_Suppl.4635 |
0.01 |
|
| 2004 |
Klotz LH. Bladder cancer markers The Canadian Journal of Urology. 11: 2426. PMID 15636667 |
0.01 |
|
| 2004 |
Klotz LH. Drugs vs OR time The Canadian Journal of Urology. 11: 2374. PMID 15576001 |
0.01 |
|
| 2004 |
Klotz LH. Industry sponsored research The Canadian Journal of Urology. 11: 2312-2313. PMID 15380051 |
0.01 |
|
| 2004 |
Klotz LH. 'Gammon's law and a change in thinking?' The Canadian Journal of Urology. 11: 2226. PMID 15287993 |
0.01 |
|
| 2004 |
Klotz LH. Geopolitics and the CJU The Canadian Journal of Urology. 11: 2169-2170. PMID 15189573 |
0.01 |
|
| 2004 |
Klotz LH. Endo urology and uro oncology The Canadian Journal of Urology. 11: 2108. PMID 15003148 |
0.01 |
|
| 2004 |
Klotz L. Cavernosal nerve mapping: Current data and applications Bju International. 93: 9-13. PMID 14678359 DOI: 10.1111/j.1464-410X.2004.04546.x |
0.01 |
|
| 2003 |
Klotz L. Active Surveillance with Selective Delayed Intervention: A Biologically Nuanced Approach to Favorable-Risk Prostate Cancer Clinical Prostate Cancer. 2: 106-110. PMID 15040871 |
0.01 |
|
| 2003 |
Klotz LH. Reassessing PSA The Canadian Journal of Urology. 10: 2032. PMID 14704105 |
0.01 |
|
| 2003 |
Klotz LH. Selling ourselves short The Canadian Journal of Urology. 10: 1969. PMID 14633323 |
0.01 |
|
| 2003 |
Klotz L. Active surveillance: An individualized approach to early prostate cancer [7] Bju International. 92: 657. PMID 14511065 DOI: 10.1046/j.1464-410X.2003.t01-7-04442.x |
0.01 |
|
| 2003 |
Klotz L. Expectant Management in 2002: Rationale and Indications Prostate Cancer: Science and Clinical Practice. 253-257. DOI: 10.1016/B978-012286981-5/50027-6 |
0.01 |
|
| 2002 |
Klotz LH. Romanow, Romanow, wherefore art thou Romanow? The Canadian Journal of Urology. 9: 1672. PMID 12517307 |
0.01 |
|
| 2002 |
Klotz L. Reactions Lancet. 360: 1869. PMID 12480379 DOI: 10.1016/S0140-6736(02)11777-6 |
0.01 |
|
| 2002 |
Klotz LH. Guidelines and trials The Canadian Journal of Urology. 9: 1623. PMID 12431322 |
0.01 |
|
| 2002 |
Klotz LH. "Sheepish about being Bullish" The Canadian Journal of Urology. 9: 1504-1505. PMID 12121578 |
0.01 |
|
| 2002 |
Klotz LO. Oxidant-induced signaling: Effects of peroxynitrite and singlet oxygen Biological Chemistry. 383: 443-456. PMID 12033434 DOI: 10.1515/BC.2002.047 |
0.01 |
|
| 2002 |
Klotz LH. Practice variation in urology The Canadian Journal of Urology. 9: 1476. PMID 12010591 |
0.01 |
|
| 2002 |
Klotz LH. Gender assignment and ideology The Canadian Journal of Urology. 9: 1442. PMID 11886596 |
0.01 |
|
| 2001 |
Klotz LH. Scientific misconduct The Canadian Journal of Urology. 8: 1392. PMID 11788015 |
0.01 |
|
| 2001 |
Klotz LH. Modernity, urology, and September 11 The Canadian Journal of Urology. 8: 1352. PMID 11718629 |
0.01 |
|
| 2001 |
Klotz L. Back to nephrectomy for patients with metastatic renal cancer Lancet. 358: 948-949. PMID 11583744 DOI: 10.1016/S0140-6736(01)06113-X |
0.01 |
|
| 2001 |
Klotz LH. Canada's Medicare gets mediocre marks The Canadian Journal of Urology. 8: 1302-1303. PMID 11564272 |
0.01 |
|
| 2001 |
Klotz L. Combined androgen blockade in prostate cancer: Meta-analyses and associated issues Bju International. 87: 806-813. PMID 11412217 DOI: 10.1046/j.1464-410X.2001.02184.x |
0.01 |
|
| 2001 |
Klotz LH. Andropause The Canadian Journal of Urology. 8: 1211. PMID 11375783 |
0.01 |
|
| 2001 |
Klotz LH. Prostate cancer screening The Canadian Journal of Urology. 8: 1182. PMID 11268305 |
0.01 |
|
| 2001 |
Klotz L. Cooperative group clinical trialsCanadian Urologic Oncology Group/Global GU Group Urologic Oncology. 6: 225-227. DOI: 10.1016/S1078-1439(01)00146-6 |
0.01 |
|
| 2001 |
Klotz L. An interpolation problem for Hilbert-Schmidt operator-valued stationary processes Zeitschrift Fur Analysis Und Ihre Anwendung. 20: 525-535. |
0.01 |
|
| 2000 |
Klotz LH. The role of nutrition in prostate cancer prevention The Canadian Journal of Urology. 7: 925. PMID 11121246 |
0.01 |
|
| 2000 |
Klotz LH. Urology as practiced in the Canadian Health Care System The Canadian Journal of Urology. 7: 958. PMID 11119437 |
0.01 |
|
| 2000 |
Klotz LH. Waiting lists The Canadian Journal of Urology. 7: 1088-1089. PMID 11114870 |
0.01 |
|
| 2000 |
Klotz LH. Allopathic versus 'holistic' medicine The Canadian Journal of Urology. 7: 1057. PMID 11109073 |
0.01 |
|
| 2000 |
Klotz L. Hormone therapy for patients with prostate carcinoma Cancer. 88: 3009-3014. PMID 10898345 |
0.01 |
|
| 2000 |
Klotz L. Intraoperative cavernous nerve stimulation during nerve sparing radical prostatectomy: How and when? Current Opinion in Urology. 10: 239-243. PMID 10858904 DOI: 10.1097/00042307-200005000-00010 |
0.01 |
|
| 2000 |
Klotz L. Neurostimulation during radical prostatectomy: Improving nerve-sparing techniques Seminars in Urologic Oncology. 18: 46-50. PMID 10719931 |
0.01 |
|
| 2000 |
Klotz L. An interpolation problem for multivariate stationary sequences Kybernetika. 36: 321-327. |
0.01 |
|
| 1999 |
Klotz L. Advances in nerve sparing for radical prostatectomy Urology. 54: 956-959. PMID 10604688 |
0.01 |
|
| 1999 |
Klotz LH. Why is the rate of testicular cancer increasing? Cmaj. 160: 213-214. PMID 9951444 |
0.01 |
|
| 1998 |
Klotz L. Orthogonal projection and restricted subordination of Hilbert-Schmidt operator-valued stationary processes Zeitschrift Fur Analysis Und Ihre Anwendung. 17: 557-563. |
0.01 |
|
| 1997 |
Klotz LH. PSAdynia and other PSA-related syndromes: A new epidemic a case history and taxonomy Urology. 50: 831-832. PMID 9426708 DOI: 10.1016/S0090-4295(97)00490-1 |
0.01 |
|
| 1997 |
Klotz LH, Sogani PC, Block NL. Summary of intermittent endocrine therapy for advanced prostate cancer (by Laurence H. Klotz, MD, Harry W. Herr, MD, Michael J. Morse, MD, and Willet F. Whitmore, Jr, MD). 1986. Seminars in Urologic Oncology. 15: 117-22. PMID 9134606 |
0.01 |
|
| 1997 |
Klotz L. The Crawford et al Article Reviewed Oncology. 11: 1163-1165. |
0.01 |
|
| 1997 |
Klotz L. The Waxman et al Article Reviewed Oncology. 11: 466-469. |
0.01 |
|
| 1994 |
Klotz L. Laparoscopic retroperitoneal lymphadenectomy for high-risk stage 1 nonseminomatous germ cell tumor: Report of four cases Urology. 43: 752-756. PMID 8165782 DOI: 10.1016/0090-4295(94)90206-2 |
0.01 |
|
| 1993 |
Klotz L. „Beschwörung durch Lachen“: Die Wirkung Velimir Chlebnikovs in deutschen Übersetzungen Zeitschrift Fur Slawistik. 38: 604-619. DOI: 10.1524/slaw.1993.38.4.604 |
0.01 |
|
| 1993 |
Klotz L. A Vitali-Hahn-Saks theorem for matrix-valued measures Archiv Der Mathematik. 60: 164-166. DOI: 10.1007/BF01199103 |
0.01 |
|
| 1992 |
Klotz L. A matrix generalization of a theorem of SzegO{combining double acute accent} Analysis Mathematica. 18: 63-72. DOI: 10.1007/BF02056661 |
0.01 |
|
| 1990 |
Klotz LH. Management of urothelial carcinoma of the upper tracts Problems in Urology. 4: 284-295. |
0.01 |
|
| 1990 |
Klotz LH. When your husband turns 50 Cmaj. 143: 1290. |
0.01 |
|
| 1984 |
Klotz LC. Is genetic engineering just another south sea bubble? Bio/Technology. 2: 104. DOI: 10.1038/nbt0184-104 |
0.01 |
|
| 1983 |
Klotz LC. Overproduction of proteins in recombinant organisms Annals of the New York Academy of Sciences. 1-11. PMID 6422822 |
0.01 |
|
| 1982 |
Klotz LP. Interpolierbarkeitskriterien für q‐dimensionale homogene verallgemeinerte Felder Mathematische Nachrichten. 109: 7-19. DOI: 10.1002/mana.19821090102 |
0.01 |
|
| 1982 |
Klotz LP. Spektraltheorie Banach‐Raum‐wertiger homogener verallgemeinerter Felder Mathematische Nachrichten. 108: 313-329. DOI: 10.1002/mana.19821080126 |
0.01 |
|
| 1981 |
Klotz LP. Einige Bemerkungen zur linearen Extrapolation stationärer verallgemeinerter Prozesse Mathematische Nachrichten. 104: 217-228. DOI: 10.1002/mana.19811040117 |
0.01 |
|
| 1980 |
Klotz L. Antiplatelet and anticoagulant therapy after coronary bypass New England Journal of Medicine. 302: 866. PMID 6965764 |
0.01 |
|
| 1970 |
Klotz L. Telangiectasia macularis eruptiva perstans. Contribution to the recognition of a peculiar form of urticaria pigmentosa Hautarzt. 21: 372-375. PMID 5518372 |
0.01 |
|
| 1965 |
Klotz L. Separation and determination of B-complex vitamins by means of synthetic ion exchange resins. 5. Determination of vitamin B 12 in vitamin B complex solutions Pharmazeutische Zentralhalle Fur Deutschland. 104: 393-401. PMID 5863404 |
0.01 |
|
| 1940 |
Klotz LJ. Uniformity in the differential enumeration of leucocytes The Journal of Laboratory and Clinical Medicine. 25: 424-434. |
0.01 |
|
| 1932 |
Klotz L. Reticuloendothel und Operation Klinische Wochenschrift. 11: 1536-1538. DOI: 10.1007/BF01987258 |
0.01 |
|
| 1932 |
Klotz L. Erwiderung Klinische Wochenschrift. 11: 1918-1918. DOI: 10.1007/BF01757019 |
0.01 |
|
| 1927 |
Klotz LJ. Inhibition of enzymatic action as a possible factor in the resistance of plants to disease Science. 66: 631-632. |
0.01 |
|
| 1926 |
Klotz L. Über Härteveränderungen des Froschgastrocnemius bei Einwirkung verschiedener Substanzen Zeitschrift FüR Die Gesamte Experimentelle Medizin. 48: 612-624. DOI: 10.1007/BF02624062 |
0.01 |
|
| 1926 |
Klotz L. Über Härte der Froschmuskeln bei Veränderungen der Zusammensetzung der Ringerlösung Zeitschrift FüR Die Gesamte Experimentelle Medizin. 48: 342-355. DOI: 10.1007/BF02624043 |
0.01 |
|
| Hide low-probability matches. |